WO2022180231A1 - Composition comprising an extract of vitis vinifera, vitamin c and probiotics for combating ageing of the skin - Google Patents
Composition comprising an extract of vitis vinifera, vitamin c and probiotics for combating ageing of the skin Download PDFInfo
- Publication number
- WO2022180231A1 WO2022180231A1 PCT/EP2022/054838 EP2022054838W WO2022180231A1 WO 2022180231 A1 WO2022180231 A1 WO 2022180231A1 EP 2022054838 W EP2022054838 W EP 2022054838W WO 2022180231 A1 WO2022180231 A1 WO 2022180231A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- extract
- composition according
- lactobacillus
- vitamin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 137
- 239000000284 extract Substances 0.000 title claims abstract description 85
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 57
- 239000006041 probiotic Substances 0.000 title claims abstract description 50
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 50
- 240000006365 Vitis vinifera Species 0.000 title claims abstract description 47
- 235000014787 Vitis vinifera Nutrition 0.000 title claims abstract description 47
- 235000002532 grape seed extract Nutrition 0.000 title claims abstract description 43
- 230000032683 aging Effects 0.000 title abstract description 7
- 229960005070 ascorbic acid Drugs 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 claims abstract description 40
- 241000894006 Bacteria Species 0.000 claims abstract description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 27
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 27
- 239000011718 vitamin C Substances 0.000 claims abstract description 27
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 25
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 45
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 45
- 239000002537 cosmetic Substances 0.000 claims description 23
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 21
- 235000013824 polyphenols Nutrition 0.000 claims description 21
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 claims description 18
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 18
- 235000011987 flavanols Nutrition 0.000 claims description 18
- 241000219095 Vitis Species 0.000 claims description 16
- 235000009392 Vitis Nutrition 0.000 claims description 16
- 201000004624 Dermatitis Diseases 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 10
- 206010015150 Erythema Diseases 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 6
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 6
- 241001303601 Rosacea Species 0.000 claims description 6
- 206010000496 acne Diseases 0.000 claims description 6
- 208000010668 atopic eczema Diseases 0.000 claims description 6
- 231100000321 erythema Toxicity 0.000 claims description 6
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 6
- 201000004700 rosacea Diseases 0.000 claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000194017 Streptococcus Species 0.000 claims description 5
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 229940039696 lactobacillus Drugs 0.000 claims description 4
- 235000013406 prebiotics Nutrition 0.000 claims description 4
- 150000001629 stilbenes Chemical class 0.000 claims description 4
- 235000021286 stilbenes Nutrition 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000194033 Enterococcus Species 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 240000007817 Olea europaea Species 0.000 claims description 3
- 235000002725 Olea europaea Nutrition 0.000 claims description 3
- 241000192001 Pediococcus Species 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 238000002798 spectrophotometry method Methods 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 2
- 241000194032 Enterococcus faecalis Species 0.000 claims description 2
- 241000194031 Enterococcus faecium Species 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 244000199866 Lactobacillus casei Species 0.000 claims description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 2
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 2
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 2
- 241000235070 Saccharomyces Species 0.000 claims description 2
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 2
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 235000011868 grain product Nutrition 0.000 claims description 2
- 229940017800 lactobacillus casei Drugs 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 241000195940 Bryophyta Species 0.000 claims 1
- 240000006432 Carica papaya Species 0.000 claims 1
- 235000009467 Carica papaya Nutrition 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 235000011929 mousse Nutrition 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 12
- 210000003491 skin Anatomy 0.000 description 30
- 230000009759 skin aging Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 235000016709 nutrition Nutrition 0.000 description 12
- 241000282412 Homo Species 0.000 description 10
- 230000036542 oxidative stress Effects 0.000 description 10
- 235000005487 catechin Nutrition 0.000 description 9
- 150000001765 catechin Chemical class 0.000 description 9
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 235000012734 epicatechin Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000470 constituent Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 6
- 239000005913 Maltodextrin Substances 0.000 description 6
- 229940035034 maltodextrin Drugs 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 244000215068 Acacia senegal Species 0.000 description 4
- 241000219112 Cucumis Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 229920000084 Gum arabic Polymers 0.000 description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000011200 topical administration Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- FQWLMRXWKZGLFI-YVYUXZJTSA-N (-)-trans-epsilon-viniferin Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-YVYUXZJTSA-N 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000009842 Cucumis melo Nutrition 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- FQWLMRXWKZGLFI-UHFFFAOYSA-N cis epsilon-viniferine Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 235000010958 polyglycerol polyricinoleate Nutrition 0.000 description 2
- 239000003996 polyglycerol polyricinoleate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 102000004722 NADPH Oxidases Human genes 0.000 description 1
- 108010002998 NADPH Oxidases Proteins 0.000 description 1
- 241000795633 Olea <sea slug> Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- -1 quercetin glycosides Chemical class 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000008491 skin homeostasis Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to a composition
- a composition comprising at least one extract of Vitis vinifera, vitamin C, and at least one probiotic bacterium and/or probiotic yeast.
- Such a composition is intended to be used for preventing and/or combating skin aging in humans or animals.
- Oxidative stress is caused by an imbalance between reactive species, also called “reactive oxygen species” (ROS), originating from the metabolism of oxygen and nitrogen, and antioxidants.
- ROS reactive oxygen species
- Free radicals are constantly produced by the organism in the cells, in particular at the level of the mitochondria. Many biological processes such as respiration, inflammation, hormone intervention or synthesis, programmed cell death, but also exogenous factors such as pollution, physiological stress, physical inactivity, smoking or UV exposure may be involved in the production of free radicals.
- Oxidative stress is visibly reflected, at the skin level, by a loss of elasticity and firmness, but also by pigmentation disorders. Also, oxidative stress promotes the appearance of fine lines and wrinkles and therefore skin aging. Oxidative stress can also alter the physiological function of the skin, ie its role as a “barrier” which protects the body in particular against pathogens but also against water loss. Consequently, oxidative stress inevitably leads to a decrease in skin hydration, reinforces the fragility of the barrier vis-à-vis the external environment and thus promotes skin ageing. The contribution of antioxidants makes it possible to reduce these deleterious effects on the appearance and function of the skin. Patent FR 3049858 thus describes a cosmetic composition comprising such antioxidants for combating skin aging.
- the immune system also produces reactive species through the activation of neutrophils which then produce free radicals in significant quantities.
- immune cells are particularly sensitive to oxidative stress. Also, an increase in oxidative stress is often associated with a decrease in immune functions.
- Vitamin C is known to play a major role both in skin homeostasis, in the body's defenses against oxidative damage, and in immune functions.
- Probiotics are well known for their beneficial effects on the immune functions, in particular at the digestive level, but also at the level of the otorhinolaryngeal (ENT) sphere. More recently, studies have shown that certain probiotic strains could also play a role against oxidative stress and against pro-inflammatory processes.
- the present invention provides a new composition comprising at least vitamin C, at least one extract of Vitis vinifero and at least one probiotic bacterium and/or probiotic yeast.
- Such a composition is not known from the prior art.
- the combination of an extract of Vitis vinifero comprising polyphenols, vitamin C and at least one probiotic bacterium and/or probiotic yeast is particularly advantageous.
- Such an association makes it possible to obtain a synergistic effect for combating skin aging compared to the extract, the vitamin C or the probiotic consumed individually by humans or animals.
- polyphenols are well known for having antimicrobial activity. However, unexpectedly, the combination of polyphenols provided by the extract of Vitis vinifero does not exhibit such deleterious effects on the probiotics of the invention.
- the present invention provides a new composition comprising: at least vitamin C, at least one extract of Vitis vinifero, and at least one probiotic bacterium and/or probiotic yeast.
- the extract of Vitis vinifera preferably comprises a mixture of molecules comprising at least 50% of total polyphenols measured by spectrophotometry at OD280nm, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, said total polyphenols comprising:
- the probiotic bacterium and/or probiotic yeast integrated into the present composition is preferably chosen from bacteria and/or yeasts of the genus Lactobacillus, Bifidobocterium, Streptococcus, Socchoromyces, Enterococcus, Pediococcus, Escherichia and mixtures thereof.
- composition according to the invention may also comprise superoxide dismutase (SOD), preferably from melon.
- SOD superoxide dismutase
- Said composition may be in the form of a nutritional composition, a cosmetic composition or a food supplement for preventing and/or combating normal skin aging in a healthy subject or the symptoms of “razor burn” or against damage resulting from exposure to pollution.
- composition is intended to be used for an anti-aging and/or moisturizing cosmetic effect and/or to fight against "razor burn” and/or to prevent and/or fight against skin aging. .
- It may also be in the form of a medicament or a pharmaceutical composition for preventing and/or treating skin pathologies chosen from acne and/or dermatitis and/or erythema and/or eczema. and/or rosacea.
- the invention relates to a cosmetic use of the composition as well as a cosmetic treatment process.
- nutritional composition is meant within the meaning of the invention any mixture of food compounds intended to be ingested by a healthy subject and comprising vitamin C, an extract of Vitis vinifera and at least one probiotic bacterium and/or or probiotic yeast.
- the nutritional compositions are in particular food compositions, foods or drinks, but can also be food supplements.
- composition or “drug” is meant in the sense of the invention any composition comprising at least one active substance presented as having curative or preventive properties with regard to human or animal diseases used alone or associated to other active or non-active substances and intended to be ingested by a pathological subject.
- a composition comprising vitamin C, an extract of Vitis vinifero and at least one probiotic bacterium and/or probiotic yeast.
- Said pharmaceutical composition or medicinal product is intended for humans or animals in the prevention and/or treatment of skin pathologies such as acne and/or dermatitis and/or erythema and/or eczema and /or rosacea.
- health subject in the sense of the invention a subject who may be a human or an animal not suffering from any skin pathology such as acne and / or dermatitis and / or erythema and/or eczema and/or rosacea.
- pathological subject is understood to mean, within the meaning of the invention, a subject who suffers from at least one skin pathology such as acne and/or dermatitis and/or erythema and /or eczema and/or rosacea.
- an extract of Vitis vinifero is meant a set of molecules obtained from an extract of Vitis vinifera.
- the raw material of Vitis vinifero can be the leaves and/or the fruits and/or the pips and/or the woods, preferentially the raw material of Vitis vinifero is the aerial part of the plant, that is to say the all the leaves, fruits, skin (skin), pips and wood, more preferably the skin (skin) and the pips.
- At least 15% of flavanol monomers is meant either at least 15% of catechins and/or epicatechins if there are no other flavanol monomers in the mixture, or at least 15% of catechins if there are no epicatechins in the mixture, or at least 15% of epicatechins if there are no catechins in the mixture, or at least 15% of the mixture of catechins and d epicatechins if both catechins and epicatechins are present in the mixture.
- at least 15% of the mixture of catechins and epicatechins is meant.
- ppm parts per million (mg/kg) in the mixture. Unless otherwise stated, ppm refers to a weight based on the total weight of the mixture.
- SOD from vine or “SOD from Vitis vinifero” is meant, within the meaning of the invention, SOD obtained from a vine leaf extract, preferably from Vitis vinifera.
- the extract of Vitis vinifero providing SOD is different from the extract comprising at least 50% of total polyphenols as described above in the sense that said extract rich in polyphenols contains little (in trace form) or no SOD.
- the extract comprising SOD can in particular be obtained according to the method described in patent FR3003164.
- the bacterium and/or probiotic yeast is meant in the sense of the invention a bacterium or bacteria of the same genus or species but also a mixture of bacteria of different genera or of different species. The probiotic bacteria and/or yeast is therefore also understood as the probiotic bacteria and/or yeasts.
- the object of the invention is therefore to provide a composition having improved efficacy in preventing and/or combating skin aging and thus having an anti-aging and/or moisturizing cosmetic effect.
- the subject of the present invention is therefore a composition comprising: at least vitamin C, at least one extract of Vitis vinifera, and at least one probiotic bacterium and/or probiotic yeast.
- Vitamin C (ascorbic acid) has characteristics suitable for a cosmetic, nutritional, food application, as a food supplement or as a medicine. It can come from a natural product, in particular fruits and vegetables such as guavas, kiwis, oranges, strawberries, broccoli, grapefruit, acerola or from a synthetic product.
- the vitamin C is present in the composition in an amount of at least 1 mg/g of dry matter of the total weight of the composition.
- the amount of vitamin C present in the composition is preferably equivalent to an administration amount of at least 4 mg per day, ie at least 5% of the Nutritional Reference Value (NRV).
- NSV Nutritional Reference Value
- the extract of Vitis vinifera present in the present composition preferably comprises a mixture of molecules comprising at least 50% of total polyphenols measured by spectrophotometry at an OD280nm, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, said total polyphenols comprising: at least 15% of flavanol monomers, preferably comprising catechins and epicatechins, measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, at least 5% of flavanol oligomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the Vitis vinifera extract.
- Catechins and epicatechins are compounds of the flavonoid family, in particular of the flavanol subclass, preferably flavanol monomers. They are also known as catechol and epicatechol and are powerful antioxidants.
- the Vitis vinifera extract comprises a mixture of molecules also comprising stilbenes such as resveratrol and/or its oligomers or polymers such as epsilon viniferine, in particular said mixture comprises at least 15 ppm of stilbenes, the weight being given by dry weight relative to the total dry weight of the extract of Vitis vinifera.
- stilbenes such as resveratrol and/or its oligomers or polymers such as epsilon viniferine
- said mixture comprises at least 15 ppm of stilbenes, the weight being given by dry weight relative to the total dry weight of the extract of Vitis vinifera.
- Resveratrol is particularly known to be present in grapes. However, it can also be derived from other plant sources, in particular from Polygonum cuspidatum but also by biotechnological means. It has many beneficial activities for humans or animals including its antioxidant effects to fight against skin aging.
- Quercetin and the consumption of foods rich in anthocyanidins helps to fight against cellular ageing.
- the Vitis vinifera extract comprising at least 50% of total polyphenols can be obtained from an extract of grape marc and/or grape seed, more preferably the Vitis vinifera extract is obtained from of a grape seed extract and an extract of grape marc.
- the extract of Vitis vinifera can also comprise stilbenes (resveratrol and/or its oligomers or polymers in particular epsilon viniferine) with a concentration of at least 15 ppm.
- the extract of Vitis vinifera can be obtained from a raw material that includes skins, stalks or stems with or without grape seeds.
- a particularly suitable method for obtaining an extract of Vitis vinifera comprises the following steps: a.
- the amount of water or hydroalcoholic solution (30% v/v to 96% V/V) added is between 2 and 10 times the mass of raw material used.
- the duration of the extraction can be between 30 minutes and 24 hours and the extraction temperature between 20°C and 80°C.
- the Raw materials used can be in dry, fresh, or frozen whole or ground form.
- the method may optionally comprise removal of the alcohol by evaporation under vacuum at a temperature, preferably below 60° C. and at a pressure below 100 mbars.
- a specific stage of the process may make it possible to obtain a purified extract rich in flavanol monomers either: i.
- extract B is a purified extract rich in flavanol monomers called extract B. f.
- An additional step may allow chromatographic purification of extract A and/or extract B.
- This step will consist of passing over a chromatographic column containing adsorption resins particularly suitable for polyphenols and known to those skilled in the art. art, extracts A and/or B then rinsing the resins using an aqueous solution followed by an elution phase using a hydroethanolic solution preferably between 60 and 80% v /vg The alcohol of the eluates thus obtained will then be evaporated and the eluate concentrated via a vacuum concentration step of the eluates rich in polyphenols and more particularly in flavanol monomers and/or in e-viniferin at a temperature preferably below 60° C. and a pressure below 100 mbar; h.
- An additional step will consist in drying the purified extracts by techniques known to those skilled in the art such as atomization, drying in a vacuum oven or drying by freeze-drying with or without a support such as maltodextrin, gum arabic for example.
- the process for preparing the composition may comprise the mixture of extracts of Vitis vinifero rich on the one hand in flavanol monomers and on the other hand in e-viniferin.
- a mixture of Vitis vinifera extract rich in polyphenol obtained according to the preceding steps can be combined with an extract rich in SOD which can be obtained according to a method as described in patent FR3003164.
- composition according to the invention also comprises at least one probiotic bacterium and/or probiotic yeast which, combined with the extract of Vitis vinifera and with vitamin C, makes it possible to substantially increase the anti-aging efficacy.
- probiotic bacterium and/or probiotic yeast which, combined with the extract of Vitis vinifera and with vitamin C, makes it possible to substantially increase the anti-aging efficacy.
- the specific combination as well as the quantity of the molecules found in the present composition makes it possible to obtain an effect on skin aging in humans or animals, this effect being better than that of constituents of the present invention taken alone or cosmetic compositions of the prior art.
- Said probiotic bacterium and/or probiotic yeast integrated into the present composition is preferably chosen from bacteria and/or yeasts of the genus Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Enterococcus, Pediococcus, Escherichia and mixtures thereof.
- the probiotic bacterium and/or yeast is chosen from the species Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus delbrueckii ssp bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium animaiis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium animaiis, Bifidobacterium bifidum, Bifidobacterium breve, Streptococcus thermophiles, Sacaromyces cerevisiae, Streptococcus faecium, Enterococcus Faecalis, Escherich
- the probiotic bacteria and/or probiotic yeast is dead, inactivated, semi-inactivated or alive, in the form of spores or not.
- the composition daily provides between 1 ⁇ 10 5 and 9 ⁇ 10 12 CFU, preferably between 1 ⁇ 10 7 and 9 ⁇ 10 11 of a probiotic bacterium and/or yeast and/or of a mixture.
- composition according to the invention also comprises superoxide dismutase (SOD).
- SOD superoxide dismutase
- the SOD is preferably an SOD derived from melon (Cucumis melo), vine (Vitis vinifera) or olive tree (Olea europeoe), because it has very good antioxidant properties and characteristics suitable for cosmetic application. More preferably, the SOD is an SOD derived from melon (Cucumis melo).
- the composition therefore preferably comprises a melon, vine or olive tree extract containing SOD.
- the extract When the extract is from a vine, it may be an extract of Vitis vinifero but said extract is not an extract of Vitis vinifera comprising at least 50% of total polyphenols including at least 15% of catechins and/or epicatechins and/ or at least 5% flavanol oligomers.
- Said extract providing SOD can be obtained by a process for obtaining SOD or the extract containing SOD by aqueous extraction, without organic solvent.
- SOD is indeed a particularly fragile molecule which requires mild extraction conditions.
- the SOD may also optionally be a synthetic SOD.
- the vine extract preferably an extract of Vitis vinifera is encapsulated or microencapsulated.
- said extract is encapsulated or microencapsulated in a food carrier chosen from maltodextrin, gum arabic, hydrogenated or non-hydrogenated oil, wax, alginates, starch, hydrolyzed or non-hydrolyzed proteins, phosphatidylcholine, phospholipids, galactomannan, emulsifiers chosen from pectin or polyglycerol polyricinoleate and fibers chosen from polydextrose, HPMC and cellulose. Encapsulation is particularly advantageous and makes it possible to stabilize and protect the extract.
- extract is meant a molecule or a mixture of molecules obtained from these plants.
- the extracts containing SOD incorporated into the compositions according to the invention may consist exclusively of SOD or else of SOD and one or more other molecules such as polyphenols with an SOD content of at least 100 IU/g of material. dry matter of the extract and even more preferably at least 500 IU/g of dry matter of the extract and even more preferably at least 1000 111/g of dry matter of the extract.
- the SOD (or the extract containing SOD) used according to the invention is preferably associated with a suitable vehicle for the intended use: external use for a cosmetic composition or a medicament for topical administration; ingestion and assimilation by the body for a food composition or a food supplement or a medicament for oral administration.
- the SOD is microencapsulated beforehand within polymeric biodegradable microparticles or lipid substances.
- the SOD/Vitamin C ratio in the composition is preferably between 1 and 50 and the SOD is present in the composition in an amount of at least 100 IU/g. of dry matter of the total weight of the composition, preferably at least 500 IU/g of dry matter of the total weight of the composition.
- composition according to the invention in addition to SOD, vitamin C, Vitis vinifera extract and probiotics, may contain other active molecules that are effective in combating skin aging, such as zinc and/or at least one other vitamin chosen from vitamins B1, B2, B3, B3/PP, B5, B6, B8/H, B9, B12, E and D.
- Said vitamins may be derived from natural products, in particular fruits and vegetables or synthetic products.
- the composition may also comprise at least one prebiotic chosen from inulin, oligosaccharides, FOS (fructo-oligosaccharides), GOS (galacto-oligosaccharides), CLA (conjugated fatty linoleic acid), PUFA (polyunsaturated acid) , MOS (mannanoligosaccharide) and XOS (xylooligosaccharide).
- prebiotic chosen from inulin, oligosaccharides, FOS (fructo-oligosaccharides), GOS (galacto-oligosaccharides), CLA (conjugated fatty linoleic acid), PUFA (polyunsaturated acid) , MOS (mannanoligosaccharide) and XOS (xylooligosaccharide).
- compositions exhibits an improved effect on skin aging.
- composition according to the invention can be administered orally in the form of a food supplement, a nutritional product or a medicine or applied topically to the skin in the form of a cosmetic product or a medicine suitable for topical application.
- composition also comprises excipients suitable in depending on its mode of administration.
- composition for oral administration, it may be in particular maltodextrin, starch, gum arabic, vegetable oil, sorbitol or water.
- the composition is then in the form of a powder, an oil or a liquid solution.
- composition for topical administration to the skin, it may be in particular water, vegetable, mineral or silicone oils, vegetable fats.
- the composition is then in the form of a cream, ointment, emulsion, gel or lotion.
- the composition is encapsulated or microencapsulated, preferably the composition is encapsulated or microencapsulated in a food carrier chosen from maltodextrin, gum arabic, hydrogenated or non-hydrogenated oil, wax, alginates, starch, hydrolyzed or non-hydrolyzed proteins, phosphatidylcholine, phospholipids, galactomannan, emulsifiers chosen from pectin or polyglycerol polyricinoleate and fibers chosen from polydextrose, HPMC and cellulose.
- a food carrier chosen from maltodextrin, gum arabic, hydrogenated or non-hydrogenated oil, wax, alginates, starch, hydrolyzed or non-hydrolyzed proteins, phosphatidylcholine, phospholipids, galactomannan, emulsifiers chosen from pectin or polyglycerol polyricinoleate and fibers chosen from polydextrose, HPMC and cellulose.
- Encapsulation is particularly advantageous and makes it possible to stabilize and protect the Vitis vinifera extract and/or the probiotic(s) (bacteria and/or yeasts) from its environment, in particular from the organism.
- encapsulation makes it possible to improve the stability, the bioavailability and the use of said extract in food matrices, with in particular masking of the taste and resistance to possible alterations of the compounds during the stages of production of a food product.
- Microencapsulation provides the same advantages as encapsulation but more particularly makes it possible to insert active substances into particles of size between 1 ⁇ m and 1000 ⁇ m and more preferentially between 30 ⁇ m and 500 ⁇ m and even more preferentially between 50pm and 300pm.
- composition according to the invention is intended to be administered as a nutritive product and can therefore be in different forms, preferably in the form of powder, capsule, tablet, capsule, solution, suspension , emulsion or chewing gum.
- composition When the composition is intended to be administered as a nutritional product, it can also be in the form of a food product, preferably in the form of dairy products, purees, cereals, cereal products and drinks.
- the invention When the composition is administered as a therapeutic product, the invention relates to a composition for its use as a medicament for humans or animals and can be in different forms, preferably in the form of powder, capsule, tablet, effervescent tablet, capsule, solution, suspension.
- the composition according to the invention is preferably intended for use in the prevention and/or treatment of skin pathologies chosen from acne and/or dermatitis and/or erythema and/or eczema and/or rosacea.
- the composition also exhibits a cutaneous anti-aging cosmetic effect in a healthy subject which is characterized in particular by the reduction of cutaneous imperfections (spots, redness, dark circles, etc.), the maintenance or restoration of firmness and the elasticity of the skin, the improvement of the complexion of the skin (colors, luminosity, contrast, shine, etc.), the maintenance or restoration of good hydration of the skin.
- the composition can be obtained by the process comprising the following steps.
- a mixer for example of the ribbon, V, plowshare type (not exhaustive)
- the compounds in dry form will be mixed.
- a premix with the extract containing SOD alone or with vitamin C, added to a quantity of excipient not exceeding 80% by weight of the premix may be manufactured before being itself mixed with the total excipients and other constituents of the formula.
- the mixing operation may last between 5 minutes and 30 minutes.
- the method may consist in directly adding vitamin C with the other constituents of the formula with stirring for 5 to 30 minutes at a temperature below 40° C., preferably and optionally under inert gas.
- compositions in liquid, pasty or gelled forms it is appropriate, with stirring, to finely disperse the vitamin C in the hydrophilic phase.
- the composition comprises SOD
- the extract containing the SOD may itself be finely dispersed in the lipophilic phase containing an emulsifier.
- the temperature of the lipophilic phase will preferably not exceed 40°C.
- the 2 phases can then be mixed between 5 minutes and 30 minutes until a homogeneous mixture is obtained.
- the product once mixed, will be packaged in the galenic adapted to the finished product (capsule, tablet, stick) according to conventional techniques known to those skilled in the art.
- the mixture may be homogenized using a homogenizer and may also possibly undergo a pasteurization or sterilization step before packaging according to known and conventional techniques. of career.
- the invention also relates to a method for the cosmetic treatment of the skin, to prevent and/or combat the visible manifestations of normal aging of the skin, which consists in applying to the skin, in particular to the skin of the face, at least once a day, a cosmetic composition according to the invention, suitable for topical administration to the skin. Twice daily application is preferred.
- the invention also relates to a cosmetic treatment process for preventing and/or combating the visible manifestations of normal skin aging, which consists in ingesting, at least once a day, a nutritional composition or a cosmetic composition according to the invention suitable for oral administration, in particular a food supplement with a cosmetic effect.
- the invention is aimed at a cosmetic use of the composition according to the invention, for an anti-aging and/or moisturizing cosmetic effect and/or for combating razor burn.
- the cosmetic use of the present composition aims to obtain a cosmetic effect allowing:
- Example 1 Nutritional composition intended for humans [0095]
- Example 1 is a 381 mg capsule, consisting of:
- Vitis vinifero 250 mg Vitamin C: 6 mg Blend of 6 probiotics (Lactobacillus fermentum, L plantarum, L acidophilus, Bfidobacterium lactis, B. longum, B. bifidum) 3c10 L 9 CFU: 75 mg Maltodextrin: 50 mg.
- composition is obtained by mixing the constituents under the conventional conditions known to those skilled in the art, and placed in a capsule according to the conventional conditions as well.
- the recommended dosage is 2 capsules per day.
- Example 2 Nutritional composition intended for humans [0097]
- Example 2 is a 3200 mg sachet, consisting of:
- Blend of 3 probiotics (Lactobacillus acidophilus, Bifidobacterium bifidum,
- Lactobacillus fermentum 4c10 L 9 CFU: 2300 mg
- Vitamin B6 0.5mg
- composition is obtained by mixing the constituents under conventional conditions known to those skilled in the art and is in the form of a powder contained in a sachet also under conventional conditions.
- the recommended dosage is 1 sachet per day.
- Example 3 Nutritional composition intended for animals [0099]
- Example 3 is a soft capsule consisting of:
- composition is obtained by mixing the constituents under the standard conditions known to those skilled in the art and is in the form of a soft capsule also under the standard conditions.
- the recommended dosage is 1 capsule per day.
- Example 4 Nutritional composition intended for the animal
- Example 4 is a tablet consisting of:
- Blend of 5 probiotics (Lactobacillus acidophilus, L. plantarum, L Brevis, Bifidobacterium animalis lactis, Lactobacillus ramnosus) 2c10 L 9 CFU: 26.5 mg - FOS: 250 mg.
- composition is obtained by mixing the constituents under the standard conditions known to those skilled in the art and is in the form of a tablet also under the standard conditions.
- the recommended dosage is 1 tablet per day for a 10 kg dog.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a composition comprising at least one extract of Vitis vinifera, vitamin C, and at least one probiotic bacterium and/or probiotic yeast. Such a composition is intended to be used for preventing and/or combating ageing of the skin in humans or animals.
Description
COMPOSITION COMPRENANT UN EXTRAIT DE VITIS VINIFERA, DE LA VITAMINE C ET DES PROBIOTIQUES POUR LUTTER CONTRE LE VIEILLISSEMENT DE LA PEAU COMPOSITION COMPRISING AN EXTRACT OF VITIS VINIFERA, VITAMIN C AND PROBIOTICS TO FIGHT AGAINST SKIN AGING
[0001] Domaine technique [0001] Technical area
[0002] L'invention concerne une composition comprenant au moins un extrait de Vitis vinifera, de la vitamine C, et au moins une bactérie probiotique et/ou levure probiotique. Une telle composition est destinée à être utilisée pour prévenir et/ou lutter contre le vieillissement de la peau chez l'Homme ou l'animal. The invention relates to a composition comprising at least one extract of Vitis vinifera, vitamin C, and at least one probiotic bacterium and/or probiotic yeast. Such a composition is intended to be used for preventing and/or combating skin aging in humans or animals.
[0003] Art antérieur [0003] Prior art
[0004] Le stress oxydatif est causé par un déséquilibre entre les espèces réactives aussi appelées « espèces réactives de l'oxygène » (ERO), provenant du métabolisme de l'oxygène et de l'azote et les antioxydants. [0004] Oxidative stress is caused by an imbalance between reactive species, also called “reactive oxygen species” (ROS), originating from the metabolism of oxygen and nitrogen, and antioxidants.
[0005] Les radicaux libres sont produits en permanence par l'organisme dans les cellules, en particulier au niveau des mitochondries. De nombreux processus biologiques tels que la respiration, l'inflammation, l'intervention ou la synthèse d'hormones, la mort cellulaire programmée, mais également des facteurs exogènes tels que la pollution, le stress physiologique, la sédentarité, le tabagisme ou l'exposition aux UV peuvent être impliqués dans la production de radicaux libres. [0005] Free radicals are constantly produced by the organism in the cells, in particular at the level of the mitochondria. Many biological processes such as respiration, inflammation, hormone intervention or synthesis, programmed cell death, but also exogenous factors such as pollution, physiological stress, physical inactivity, smoking or UV exposure may be involved in the production of free radicals.
[0006] Au cours du temps, le stress oxydatif se traduit visiblement, au niveau cutané, par une perte d'élasticité, de fermeté mais également par des troubles de la pigmentation. Aussi, le stress oxydatif favorise l'apparition de ridules et rides et donc le vieillissement cutané. Le stress oxydatif peut également altérer la fonction physiologique de la peau, c'est-à-dire son rôle de « barrière » qui protège l'organisme notamment contre les pathogènes mais également contre la perte en eau. Par conséquent, le stress oxydant conduit inévitablement à une diminution de l'hydratation de la peau, renforce la fragilité de la barrière vis-à-vis de l'environnement extérieur et promeut ainsi le vieillissement cutané. L'apport d'anti-oxydants permet de réduire ces effets délétères sur l'apparence et la fonction de la peau. Le brevet FR 3049858 décrit ainsi une composition cosmétique comprenant de tels antioxydants pour lutter contre le vieillissement de la peau. [0006] Over time, oxidative stress is visibly reflected, at the skin level, by a loss of elasticity and firmness, but also by pigmentation disorders. Also, oxidative stress promotes the appearance of fine lines and wrinkles and therefore skin aging. Oxidative stress can also alter the physiological function of the skin, ie its role as a “barrier” which protects the body in particular against pathogens but also against water loss. Consequently, oxidative stress inevitably leads to a decrease in skin hydration, reinforces the fragility of the barrier vis-à-vis the external environment and thus promotes skin ageing. The contribution of antioxidants makes it possible to reduce these deleterious effects on the appearance and function of the skin. Patent FR 3049858 thus describes a cosmetic composition comprising such antioxidants for combating skin aging.
[0007] D'autre part, la production élevée de radicaux libres peut également être liée au
processus inflammatoire. En effet, l'activation des phagocytes induit l'activation de la NADPH oxydase, qui catalyse la production d'une quantité importante d'espèces réactives (radical superoxyde). Réciproquement, un stress oxydant excessif conduit à une augmentation de la production de molécules pro-inflammatoires. Pour cette raison, le stress oxydant est impliqué dans l'étiologie de certaines pathologies inflammatoires. [0007] On the other hand, the high production of free radicals can also be linked to the inflammatory process. Indeed, the activation of phagocytes induces the activation of NADPH oxidase, which catalyzes the production of a large quantity of reactive species (superoxide radical). Conversely, excessive oxidative stress leads to an increase in the production of pro-inflammatory molecules. For this reason, oxidative stress is implicated in the etiology of certain inflammatory pathologies.
[0008] Le système immunitaire produit également des espèces réactives grâce à l'activation des neutrophiles qui produisent alors des radicaux libres en quantité significative. Or, les cellules immunitaires sont particulièrement sensibles au stress oxydatif. Aussi, une augmentation du stress oxydatif est souvent associée à une diminution des fonctions immunitaires. [0008] The immune system also produces reactive species through the activation of neutrophils which then produce free radicals in significant quantities. However, immune cells are particularly sensitive to oxidative stress. Also, an increase in oxidative stress is often associated with a decrease in immune functions.
[0009] La vitamine C est connue pour jouer un rôle majeur à la fois dans l'homéostasie cutanée, dans les défenses de l'organisme contre les dommages oxydatifs, et dans les fonctions immunitaires. [0009] Vitamin C is known to play a major role both in skin homeostasis, in the body's defenses against oxidative damage, and in immune functions.
[0010] Les polyphénols, notamment les polyphénols de raisin, sont bien connus pour leur puissant pouvoir anti-oxydant, et ce par voie orale comme par voie topique. Plusieurs études précliniques et cliniques enseignent des effets bénéfiques sur le vieillissement cutané, en particulier sur l'homogénéité du teint ainsi que sur la protection des cellules cutanées contre les dommages induits par l'exposition aux UV. [0010] Polyphenols, in particular grape polyphenols, are well known for their powerful antioxidant power, both orally and topically. Several preclinical and clinical studies show beneficial effects on skin aging, in particular on the homogeneity of the complexion as well as on the protection of skin cells against damage induced by UV exposure.
[0011] Les probiotiques sont bien connus pour leurs effets bénéfiques sur les fonctions immunitaires, notamment au niveau digestif, mais également au niveau de la sphère oto- rhino-laryngée (ORL). Plus récemment, des études ont montré que certaines souches probiotiques pouvaient aussi jouer un rôle contre le stress oxydant et contre les processus pro inflammatoires. [0011] Probiotics are well known for their beneficial effects on the immune functions, in particular at the digestive level, but also at the level of the otorhinolaryngeal (ENT) sphere. More recently, studies have shown that certain probiotic strains could also play a role against oxidative stress and against pro-inflammatory processes.
[0012] Les effets bénéfiques de la vitamine C, des polyphénols, des probiotiques pris individuellement sont ainsi connus dans la prévention et la lutte contre le vieillissement cutanée chez l'Homme ou l'animal. [0012] The beneficial effects of vitamin C, polyphenols and probiotics taken individually are thus known in preventing and combating skin aging in humans or animals.
[0013] Cependant, le vieillissement cutané reste une préoccupation majeure pour de très nombreuses personnes. Aussi, il existe toujours un besoin pour une nouvelle solution permettant de prévenir et/ou lutter contre le vieillissement de la peau chez l'Homme ou l'animal avec une efficacité améliorée par rapport à l'art antérieur. C'est l'objectif de la présente invention. [0013] However, skin aging remains a major concern for a large number of people. Also, there is still a need for a new solution making it possible to prevent and/or fight against skin aging in humans or animals with improved efficiency compared to the prior art. This is the objective of the present invention.
[0014] Résumé de l'invention
[0015] Pour répondre à ce besoin, la présente invention propose une nouvelle composition comprenant au moins de la vitamine C, au moins un extrait de Vitis vinifero et au moins une bactérie probiotique et/ou levure probiotique. [0014] Summary of the Invention To meet this need, the present invention provides a new composition comprising at least vitamin C, at least one extract of Vitis vinifero and at least one probiotic bacterium and/or probiotic yeast.
[0016] Une telle composition n'est pas connue de l'art antérieur. Or, l'association d'un extrait de Vitis vinifero comprenant des polyphénols, de la vitamine C et d'au moins une bactérie probiotique et/ou levure probiotique est particulièrement avantageuse. Une telle association permet d'obtenir un effet synergique pour lutter contre le vieillissement de la peau par rapport à l'extrait, la vitamine C ou le probiotique consommé individuellement par l'Homme ou l'animal. [0016] Such a composition is not known from the prior art. However, the combination of an extract of Vitis vinifero comprising polyphenols, vitamin C and at least one probiotic bacterium and/or probiotic yeast is particularly advantageous. Such an association makes it possible to obtain a synergistic effect for combating skin aging compared to the extract, the vitamin C or the probiotic consumed individually by humans or animals.
[0017] D'autre part, les polyphénols sont bien connus pour avoir une activité antimicrobienne. Or, de façon inattendue, l'association des polyphénols apportés par l'extrait de Vitis vinifero ne présente pas de tels effets délétères sur les probiotiques de l'invention. [0017] On the other hand, polyphenols are well known for having antimicrobial activity. However, unexpectedly, the combination of polyphenols provided by the extract of Vitis vinifero does not exhibit such deleterious effects on the probiotics of the invention.
[0018] A cet effet, la présente invention propose une nouvelle composition comprenant : au moins de la vitamine C, au moins un extrait de Vitis vinifero, et au moins une bactérie probiotique et/ou levure probiotique. To this end, the present invention provides a new composition comprising: at least vitamin C, at least one extract of Vitis vinifero, and at least one probiotic bacterium and/or probiotic yeast.
[0019] L'extrait de Vitis vinifera comprend préférentiellement, un mélange de molécules com prenant au moins 50% de polyphénols totaux mesurés par spectrophotométrie à une DO280nm, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, lesdits polyphénols totaux comprenant : [0019] The extract of Vitis vinifera preferably comprises a mixture of molecules comprising at least 50% of total polyphenols measured by spectrophotometry at OD280nm, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, said total polyphenols comprising:
■ au moins 15% de monomères de flavanols mesurés par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, ■ at least 15% of flavanol monomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the Vitis vinifera extract,
■ au moins 5% d'oligomères de flavanols mesuré par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera. ■ at least 5% of flavanol oligomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the Vitis vinifera extract.
[0020] La bactérie probiotique et/ou levure probiotique intégrée dans la présente composition est préférentiellement choisie parmi les bactéries et/ou levures du genre Lactobacillus, Bifidobocterium, Streptococcus, Socchoromyces, Enterococcus, Pediococcus, Escherichia et leurs mélanges. [0020] The probiotic bacterium and/or probiotic yeast integrated into the present composition is preferably chosen from bacteria and/or yeasts of the genus Lactobacillus, Bifidobocterium, Streptococcus, Socchoromyces, Enterococcus, Pediococcus, Escherichia and mixtures thereof.
[0021] La composition selon l'invention peut également comprendre de la superoxyde dismutase (SOD), préférentiellement issue de melon. The composition according to the invention may also comprise superoxide dismutase (SOD), preferably from melon.
[0022] Ladite composition peut être sous forme d'une composition nutritionnelle, d'une
composition cosmétique ou d'un complément alimentaire pour prévenir et/ou lutter contre le vieillissement cutané normal chez un sujet sain ou les symptômes de « feu du rasoir » ou contre les dommages résultant de l'exposition à la pollution. [0022] Said composition may be in the form of a nutritional composition, a cosmetic composition or a food supplement for preventing and/or combating normal skin aging in a healthy subject or the symptoms of “razor burn” or against damage resulting from exposure to pollution.
[0023] Ainsi, la composition est destinée à être utilisé pour un effet cosmétique anti-âge et/ou hydratant et/ou pour lutter contre le « feu du rasoir » et/ou pour prévenir et/ou lutter contre le vieillissement de la peau. [0023] Thus, the composition is intended to be used for an anti-aging and/or moisturizing cosmetic effect and/or to fight against "razor burn" and/or to prevent and/or fight against skin aging. .
[0024] Elle peut également être sous forme d'un médicament ou d'une composition pharmaceutique pour prévenir et/ou traiter des pathologies cutanées choisies parmi l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée. [0024] It may also be in the form of a medicament or a pharmaceutical composition for preventing and/or treating skin pathologies chosen from acne and/or dermatitis and/or erythema and/or eczema. and/or rosacea.
[0025] Selon un autre objet, l'invention vise une utilisation cosmétique de la composition ainsi qu'un procédé de traitement cosmétique. [0025] According to another object, the invention relates to a cosmetic use of the composition as well as a cosmetic treatment process.
[0026] D'autres caractéristiques et avantages ressortiront de la description détaillée de l'invention et des exemples qui vont suivre. Other characteristics and advantages will emerge from the detailed description of the invention and the examples which follow.
[0027] Description détaillée de l'invention [0028] Définition [0027] Detailed description of the invention [0028] Definition
[0029] Par « composition nutritionnelle », on entend au sens de l'invention tout mélange de composés alimentaires destiné à être ingéré par un sujet sain et comprenant de la vitamine C, un extrait de Vitis vinifera et au moins une bactérie probiotique et/ou levure probiotique. Les compositions nutritionnelles sont notamment des compositions alimentaires, des aliments ou des boissons, mais peuvent également être des compléments alimentaires. [0029] By "nutritional composition" is meant within the meaning of the invention any mixture of food compounds intended to be ingested by a healthy subject and comprising vitamin C, an extract of Vitis vinifera and at least one probiotic bacterium and/or or probiotic yeast. The nutritional compositions are in particular food compositions, foods or drinks, but can also be food supplements.
[0030] Par « composition pharmaceutique » ou « médicament », on entend au sens de l'invention toute composition comprenant au moins une substance active présentée comme possédant des propriétés curatives ou préventives à l'égard des maladies humaines ou animales utilisée seule ou associée à d'autres substances actives ou non et destinée à être ingérée par un sujet pathologique. Une telle composition comprenant de la vitamine C, un extrait de Vitis vinifero et au moins une bactérie probiotique et/ou levure probiotique. Ladite composition pharmaceutique ou médicament est destiné à l'Homme ou à l'animal dans la prévention et/ou le traitement de pathologies cutanées telles que l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée. [0030] By "pharmaceutical composition" or "drug" is meant in the sense of the invention any composition comprising at least one active substance presented as having curative or preventive properties with regard to human or animal diseases used alone or associated to other active or non-active substances and intended to be ingested by a pathological subject. Such a composition comprising vitamin C, an extract of Vitis vinifero and at least one probiotic bacterium and/or probiotic yeast. Said pharmaceutical composition or medicinal product is intended for humans or animals in the prevention and/or treatment of skin pathologies such as acne and/or dermatitis and/or erythema and/or eczema and /or rosacea.
[0031] Par « sujet sain », on entend au sens de l'invention un sujet qui peut être un Homme ou un animal ne souffrant d'aucune pathologie cutanée telle que l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée.
[0032] A l'inverse, par « sujet pathologique », on entend au sens de l'invention un sujet qui souffre d'au moins une pathologie cutanée telle que l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée. [0031] By "healthy subject" is meant in the sense of the invention a subject who may be a human or an animal not suffering from any skin pathology such as acne and / or dermatitis and / or erythema and/or eczema and/or rosacea. [0032] Conversely, the term “pathological subject” is understood to mean, within the meaning of the invention, a subject who suffers from at least one skin pathology such as acne and/or dermatitis and/or erythema and /or eczema and/or rosacea.
[0033] Par « un extrait de Vitis vinifero », on entend un ensemble de molécules obtenues à partir d'un extrait de Vitis vinifera. La matière première de Vitis vinifero peut être les feuilles et/ou les fruits et/ou les pépins et/ou les bois, préférentiellement la matière première de Vitis vinifero est la partie aérienne de la plante, c'est-à-dire l'ensemble des feuilles, fruits, peau (pellicule), pépins et bois, plus préférentiellement la peau (pellicule) et les pépins. [0033] By “an extract of Vitis vinifero”, is meant a set of molecules obtained from an extract of Vitis vinifera. The raw material of Vitis vinifero can be the leaves and/or the fruits and/or the pips and/or the woods, preferentially the raw material of Vitis vinifero is the aerial part of the plant, that is to say the all the leaves, fruits, skin (skin), pips and wood, more preferably the skin (skin) and the pips.
[0034] Par « au moins 15% de monomères de flavanols » on entend soit au moins 15% de catéchines et/ou épicatéchines s'il n'y a pas d'autres monomères de flavanols dans le mélange, soit au moins 15% de catéchines s'il n'y a pas d'épicatéchines dans le mélange, soit au moins 15% d'épicatéchines s'il n'y a pas de catéchines dans le mélange, soit au moins 15% du mélange de catéchines et d'épicatéchines si à la fois des catéchines et des épicatéchines sont présentes dans le mélange. Préférentiellement, on entend au moins 15% du mélange de catéchines et d'épicatéchines. [0034] By “at least 15% of flavanol monomers” is meant either at least 15% of catechins and/or epicatechins if there are no other flavanol monomers in the mixture, or at least 15% of catechins if there are no epicatechins in the mixture, or at least 15% of epicatechins if there are no catechins in the mixture, or at least 15% of the mixture of catechins and d epicatechins if both catechins and epicatechins are present in the mixture. Preferably, at least 15% of the mixture of catechins and epicatechins is meant.
[0035] Par « ppm » on entend parties par million (mg/kg) dans le mélange. Sauf indication contraire, ppm se réfère à un poids par rapport au poids total du mélange. By “ppm” is meant parts per million (mg/kg) in the mixture. Unless otherwise stated, ppm refers to a weight based on the total weight of the mixture.
[0036] Par « SOD issue de vigne », ou « SOD issue de Vitis vinifero » on entend au sens de l'invention de la SOD obtenue à partir d'un extrait de feuille de vigne, préférentiellement de Vitis vinifera. L'extrait de Vitis vinifero apportant le SOD est différent de l'extrait comprenant au moins 50% de polyphénols totaux tel que décrit précédemment dans le sens où ledit extrait riche en polyphénols ne contient peu (à l'état de trace) ou pas de SOD. L'extrait comprenant de la SOD peut notamment être obtenu selon le procédé décrit dans le brevet FR3003164. [0037] Par « la bactérie et/ou levure probiotique », on entend au sens de l'invention une bactérie ou des bactéries du même genre ou espèce mais également un mélange de bactéries de genres différents ou d'espèces différentes. La bactérie et/ou levure probiotique s'entend donc également comme les bactéries et/ou levures probiotiques. [0036] By “SOD from vine”, or “SOD from Vitis vinifero” is meant, within the meaning of the invention, SOD obtained from a vine leaf extract, preferably from Vitis vinifera. The extract of Vitis vinifero providing SOD is different from the extract comprising at least 50% of total polyphenols as described above in the sense that said extract rich in polyphenols contains little (in trace form) or no SOD. The extract comprising SOD can in particular be obtained according to the method described in patent FR3003164. [0037] By "the bacterium and/or probiotic yeast" is meant in the sense of the invention a bacterium or bacteria of the same genus or species but also a mixture of bacteria of different genera or of different species. The probiotic bacteria and/or yeast is therefore also understood as the probiotic bacteria and/or yeasts.
[0038] L'invention est à présent illustrée par des exemples non limitatifs de compositions selon l'invention et par des résultats. The invention is now illustrated by non-limiting examples of compositions according to the invention and by results.
[0039] Composition [0039] Composition
[0040] L'objectif de l'invention est donc de fournir une composition présentant une efficacité améliorée dans la prévention et/ou la lutte contre le vieillissement cutanée et présentant ainsi
un effet cosmétique anti-âge et/ou hydratant. [0040] The object of the invention is therefore to provide a composition having improved efficacy in preventing and/or combating skin aging and thus having an anti-aging and/or moisturizing cosmetic effect.
[0041] A cet effet, la présente invention a donc pour objet une composition comprenant : au moins de la vitamine C, au moins un extrait de Vitis vinifera, et au moins une bactérie probiotique et/ou levure probiotique. To this end, the subject of the present invention is therefore a composition comprising: at least vitamin C, at least one extract of Vitis vinifera, and at least one probiotic bacterium and/or probiotic yeast.
[0042] La vitamine C (acide ascorbique) présente des caractéristiques adaptées à une application cosmétique, nutritionnelle, alimentaire, comme complément alimentaire ou comme médicament. Elle peut être issue d'un produit naturel, en particulier des fruits et légumes tels que les goyaves, kiwis, orange, fraise, brocolis, pamplemousse, acerola ou d'un produit de synthèse. [0042] Vitamin C (ascorbic acid) has characteristics suitable for a cosmetic, nutritional, food application, as a food supplement or as a medicine. It can come from a natural product, in particular fruits and vegetables such as guavas, kiwis, oranges, strawberries, broccoli, grapefruit, acerola or from a synthetic product.
[0043] Préférentiellement, la vitamine C est présente dans la composition en une quantité d'au moins lmg/g de matière sèche du poids total de la composition. Ainsi, la quantité de vitamine C présente dans la composition est préférentiellement équivalente à une quantité d'administration d'au moins 4 mg par jour soit au moins 5% de la Valeur Nutritionnel de Référence (VNR). Preferably, the vitamin C is present in the composition in an amount of at least 1 mg/g of dry matter of the total weight of the composition. Thus, the amount of vitamin C present in the composition is preferably equivalent to an administration amount of at least 4 mg per day, ie at least 5% of the Nutritional Reference Value (NRV).
[0044] L'extrait de Vitis vinifera présent dans la présente composition comprend préférentiellement, un mélange de molécules comprenant au moins 50% de polyphénols totaux mesurés par spectrophotométrie à une DO280nm, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, lesdits polyphénols totaux comprenant : au moins 15% de monomères de flavanols, comprenant préférentiellement des catéchines et épicatéchines, mesurés par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, au moins 5% d'oligomères de flavanols mesuré par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera. [0045] Les catéchines et épicatéchines sont des composés de la famille des flavonoïdes, en particulier de la sous-classe des flavanols, préférentiellement des monomères de flavanols. Elles sont aussi connues sous le nom de catéchol et épicatéchol et sont de puissants antioxydants. The extract of Vitis vinifera present in the present composition preferably comprises a mixture of molecules comprising at least 50% of total polyphenols measured by spectrophotometry at an OD280nm, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, said total polyphenols comprising: at least 15% of flavanol monomers, preferably comprising catechins and epicatechins, measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, at least 5% of flavanol oligomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the Vitis vinifera extract. Catechins and epicatechins are compounds of the flavonoid family, in particular of the flavanol subclass, preferably flavanol monomers. They are also known as catechol and epicatechol and are powerful antioxidants.
[0046] Préférentiellement, l'extrait de Vitis vinifera comprend un mélange de molécules comprenant également des stilbènes tels que le resvératrol et/ou ses oligomères ou polymères
tel que l'epsilon viniférine, en particulier ledit mélange comprend au moins 15 ppm de stilbènes, le poids étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera. Preferably, the Vitis vinifera extract comprises a mixture of molecules also comprising stilbenes such as resveratrol and/or its oligomers or polymers such as epsilon viniferine, in particular said mixture comprises at least 15 ppm of stilbenes, the weight being given by dry weight relative to the total dry weight of the extract of Vitis vinifera.
[0047] Le resvératrol est particulièrement connu pour être présent dans le raisin. Toutefois, il peut également être issu d'autres sources végétales, en particulier à partir du Polygonum cuspidatum mais également par voie biotechnologique. Il possède de nombreuses activités bénéfiques pour l'Homme ou l'animal parmi lesquelles ses effets antioxydant permettant de lutter contre le vieillissement de la peau. Resveratrol is particularly known to be present in grapes. However, it can also be derived from other plant sources, in particular from Polygonum cuspidatum but also by biotechnological means. It has many beneficial activities for humans or animals including its antioxidant effects to fight against skin aging.
[0048] L'effet de la composition est particulièrement augmenté et efficace lorsqu'elle comprend également : The effect of the composition is particularly increased and effective when it also comprises:
- au moins 50 ppm de quercétines et/ou glycosides de quercétine et/ou - at least 50 ppm of quercetins and/or quercetin glycosides and/or
- au moins 500 ppm d'anthocyanines. - at least 500 ppm of anthocyanins.
[0049] La quercétine et la consommation d'aliments riches en anthocyanidines (aglycones et/ou glycosylées) permet d'aider à lutter contre le vieillissement cellulaire. [0049] Quercetin and the consumption of foods rich in anthocyanidins (aglycones and/or glycosylated) helps to fight against cellular ageing.
[0050] L'extrait de Vitis vinifera comprenant au moins 50% de polyphénols totaux peut être obtenu à partir d'un extrait de marc de raisin et/ou de pépin de raisin, plus préférentiellement l'extrait de Vitis vinifera est obtenu à partir d'un extrait de pépin de raisin et d'un extrait de marc de raisin. The Vitis vinifera extract comprising at least 50% of total polyphenols can be obtained from an extract of grape marc and/or grape seed, more preferably the Vitis vinifera extract is obtained from of a grape seed extract and an extract of grape marc.
[0051] L'extrait de Vitis vinifera peut également comprendre des stilbènes (resvératrol et/ou ses oligomères ou polymères en particulier l'epsilon viniférine) avec une concentration d'au moins 15 ppm. Poury parvenir, l'extrait de Vitis vinifera peut être obtenu à partir d'une matière première qui comprend des pellicules, des rafles ou des bois avec ou sans pépin de raisin. [0052] Un procédé particulièrement adapté pour obtenir un extrait de Vitis vinifera (fruit, pellicule, pépin, feuille, rafle, sarment, ceps, bois, racine) comprend les étapes suivantes : a. extraction à l'eau et/ou à l'alcool (notamment éthanol) de Vitis vinifera, préférentiellement des pépins de Vitis vinifera d'une part, et d'autre part de marc de raisin de Vitis vinifera (pellicules/peau, pépins, rafles) issus notamment des résidus de pressage de la fabrication du vin et/ou de feuille de Vitis vinifera et/ou de sarment, ceps, bois, racine de Vitis vinifera. La quantité d'eau ou de solution hydroalcoolique (30% v/v à 96% V/V) ajoutée est comprise entre 2 et 10 fois la masse de matière première mise en oeuvre. La durée de l'extraction peut être comprise entre 30 minutes et 24 heures et la température d'extraction comprise entre 20°C et 80°C. Les
matières premières utilisées peuvent être sous formes sèches, fraîches, ou congelées entières ou broyées. b. séparation de la solution d'eau et/ou alcool de la matière solide, par exemple par décantation centrifuge ou par pressage et filtration. L'extrait ainsi obtenu est appelé extrait brut A. c. Selon une variante, le procédé peut comprendre éventuellement une élimination de l'alcool par évaporation sous-vide à une température, préférentiellement inférieure à 60°C et à une pression inférieure à lOOmbars. d. à partir de l'extrait brut A préalablement obtenu, une étape spécifique du procédé pourra permettre d'obtenir un extrait purifié riche en monomères de flavanols soit : i. par purification par séparation membranaire d'ultrafiltration et/ou de nanofiltration connue de l'homme de l'art de l'extrait préalablement désolvanté de façon à sélectionner préférentiellement les monomères et d'éliminer les polymères de flavanols, permettant d'obtenir un extrait comprenant une fraction enrichie en monomères de flavanols ; ou ii. par purification à l'aide d'une séparation liquide/liquide par des solvants organiques connu de l'homme de l'art et en particulier par de l'acétate d'éthyle, ou iii. par purification via une précipitation aux sels tel le NaCI des polymères de flavanols suivi d'une séparation solide/liquide telles que la filtration par exemple. e. L'extrait ainsi obtenu est un extrait purifié riche en monomères de flavanols appelé extrait B. f. Une étape supplémentaire pourra permettre une purification chromatographique de l'extrait A et/ou de l'extrait B. Cette étape consistera à passer sur une colonne chromatographique contenant des résines d'adsorption particulièrement adaptée aux polyphénols et connues de l'homme de l'art, les extraits A et/ou B puis à rincer les résines à l'aide d'une solution aqueuse suivie d'une phase d'élution à l'aide d'une solution hydro éthanolique comprise de préférence entre 60 et 80% v/v. g. L'alcool des éluats ainsi obtenus sera alors évaporé et l'éluat concentré via une étape de concentration sous-vide de/des éluats riches en polyphénols et plus particulièrement en monomères de flavanols et/ou en e-viniférine à une température
préférentiellement inférieure à 60°C et une pression inférieure à 100 mbars ; h. Une étape supplémentaire consistera à sécher les extraits purifiés par des techniques connues de l'homme de l'art telle que l'atomisation, le séchage dans une étuve sous vide ou séchage par lyophilisation avec ou sans support telle que la maltodextrine, la gomme arabique par exemple. i. Une fois l'extrait obtenu, le procédé de préparation de la composition peut comprendre le mélange d'extraits de Vitis vinifero riches d'une part en monomères de flavanols et d'autre part en e-viniférine. j. Un mélange d'Extrait de Vitis vinifera riche en polyphénol obtenu selon les étapes précédente pourra être combiné avec un extrait riche en SOD pouvant être obtenu selon un procédé tel que décrit dans le brevet FR3003164. The extract of Vitis vinifera can also comprise stilbenes (resveratrol and/or its oligomers or polymers in particular epsilon viniferine) with a concentration of at least 15 ppm. To achieve this, the extract of Vitis vinifera can be obtained from a raw material that includes skins, stalks or stems with or without grape seeds. A particularly suitable method for obtaining an extract of Vitis vinifera (fruit, skin, pip, leaf, stalk, vine shoot, stock, wood, root) comprises the following steps: a. extraction with water and/or alcohol (in particular ethanol) of Vitis vinifera, preferentially pips of Vitis vinifera on the one hand, and on the other hand grape marc of Vitis vinifera (dandruff/skin, pips, stalks) resulting in particular from pressing residues from the production of wine and/or leaves of Vitis vinifera and/or vine shoots, vines, wood, root of Vitis vinifera. The amount of water or hydroalcoholic solution (30% v/v to 96% V/V) added is between 2 and 10 times the mass of raw material used. The duration of the extraction can be between 30 minutes and 24 hours and the extraction temperature between 20°C and 80°C. The Raw materials used can be in dry, fresh, or frozen whole or ground form. b. separation of the water and/or alcohol solution from the solid material, for example by centrifugal decantation or by pressing and filtration. The extract thus obtained is called crude extract A. c. According to a variant, the method may optionally comprise removal of the alcohol by evaporation under vacuum at a temperature, preferably below 60° C. and at a pressure below 100 mbars. d. from the crude extract A previously obtained, a specific stage of the process may make it possible to obtain a purified extract rich in flavanol monomers either: i. by purification by membrane separation of ultrafiltration and/or nanofiltration known to those skilled in the art of the extract desolventized beforehand so as to preferentially select the monomers and to eliminate the flavanol polymers, making it possible to obtain an extract comprising a fraction enriched in flavanol monomers; or ii. by purification using a liquid/liquid separation using organic solvents known to those skilled in the art and in particular using ethyl acetate, or iii. by purification via precipitation with salts such as NaCl of the flavanol polymers followed by a solid/liquid separation such as filtration for example. e. The extract thus obtained is a purified extract rich in flavanol monomers called extract B. f. An additional step may allow chromatographic purification of extract A and/or extract B. This step will consist of passing over a chromatographic column containing adsorption resins particularly suitable for polyphenols and known to those skilled in the art. art, extracts A and/or B then rinsing the resins using an aqueous solution followed by an elution phase using a hydroethanolic solution preferably between 60 and 80% v /vg The alcohol of the eluates thus obtained will then be evaporated and the eluate concentrated via a vacuum concentration step of the eluates rich in polyphenols and more particularly in flavanol monomers and/or in e-viniferin at a temperature preferably below 60° C. and a pressure below 100 mbar; h. An additional step will consist in drying the purified extracts by techniques known to those skilled in the art such as atomization, drying in a vacuum oven or drying by freeze-drying with or without a support such as maltodextrin, gum arabic for example. i. Once the extract has been obtained, the process for preparing the composition may comprise the mixture of extracts of Vitis vinifero rich on the one hand in flavanol monomers and on the other hand in e-viniferin. d. A mixture of Vitis vinifera extract rich in polyphenol obtained according to the preceding steps can be combined with an extract rich in SOD which can be obtained according to a method as described in patent FR3003164.
[0053] Enfin, la composition selon l'invention comprend également au moins une bactérie probiotique et/ou levure probiotique qui, associée à l'extrait de Vitis vinifera et à la vitamine C permet d'augmenter sensiblement l'efficacité anti-âge. [0054] Aussi, de manière surprenante, la combinaison spécifique ainsi que la quantité des molécules se trouvant dans la présente composition permet d'obtenir un effet sur le vieillissement cutanée chez l'Homme ou l'animal, cet effet étant meilleur que celui des constituants de la présente invention pris seul ou des compositions cosmétiques de l'art antérieur. [0055] Ladite bactérie probiotique et/ou levure probiotique intégrée dans la présente composition est préférentiellement choisie parmi les bactéries et/ou levures du genre Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Enterococcus, Pediococcus, Escherichia et leurs mélanges. Finally, the composition according to the invention also comprises at least one probiotic bacterium and/or probiotic yeast which, combined with the extract of Vitis vinifera and with vitamin C, makes it possible to substantially increase the anti-aging efficacy. Also, surprisingly, the specific combination as well as the quantity of the molecules found in the present composition makes it possible to obtain an effect on skin aging in humans or animals, this effect being better than that of constituents of the present invention taken alone or cosmetic compositions of the prior art. Said probiotic bacterium and/or probiotic yeast integrated into the present composition is preferably chosen from bacteria and/or yeasts of the genus Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Enterococcus, Pediococcus, Escherichia and mixtures thereof.
[0056] Préférentiellement, la bactérie et/ou levure probiotique est choisie parmi les espèces Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus delbrueckii ssp bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium animaiis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium animaiis, Bifidobacterium bifidum, Bifidobacterium breve, Streptococcus thermophiles, Sacaromyces cerevisiae, Streptococcus faecium, Enterococcus Faecalis, Escherichia coli et leurs mélanges. Preferably, the probiotic bacterium and/or yeast is chosen from the species Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus delbrueckii ssp bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium animaiis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium animaiis, Bifidobacterium bifidum, Bifidobacterium breve, Streptococcus thermophiles, Sacaromyces cerevisiae, Streptococcus faecium, Enterococcus Faecalis, Escherichia coli and mixtures thereof.
[0057] Préférentiellement, la bactérie probiotique et/ou levure probiotique est morte,
inactivée, semi-inactivée ou vivante, sous forme de spores ou non. [0057] Preferably, the probiotic bacteria and/or probiotic yeast is dead, inactivated, semi-inactivated or alive, in the form of spores or not.
[0058] Selon un mode de réalisation avantageux, la composition apporte journalièrement entre lxlO5 et 9xl012 UFC, préférentiellement entre lxlO7 et 9x1o11 d'une bactérie probiotique et/ou levure et/ou d'un mélange. According to an advantageous embodiment, the composition daily provides between 1×10 5 and 9×10 12 CFU, preferably between 1×10 7 and 9× 10 11 of a probiotic bacterium and/or yeast and/or of a mixture.
[0059] Selon un mode de réalisation particulièrement préféré, la composition selon l'invention comprend également de la superoxyde dismutase (SOD). According to a particularly preferred embodiment, the composition according to the invention also comprises superoxide dismutase (SOD).
[0060] La SOD est préférentiellement une SOD issue de melon ( Cucumis melo), de vigne (Vitis vinifera) ou d'olivier (Olea europeoe), car elle présente de très bonnes propriétés antioxydantes et des caractéristiques adaptées à une application cosmétique. Plus préférentiellement, la SOD est une SOD issue de melon ( Cucumis melo). The SOD is preferably an SOD derived from melon (Cucumis melo), vine (Vitis vinifera) or olive tree (Olea europeoe), because it has very good antioxidant properties and characteristics suitable for cosmetic application. More preferably, the SOD is an SOD derived from melon (Cucumis melo).
[0061] La composition comprend donc préférentiellement un extrait de melon, de vigne ou d'olivier contenant de la SOD. Lorsque l'extrait est issu de vigne, ce peut être un extrait de Vitis vinifero mais ledit extrait n'est pas un extrait de Vitis vinifera comprenant au moins 50% de polyphénols totaux dont au moins 15% de catéchines et/ou épicatéchines et/ou au moins 5% d'oligomères de flavanols. Ledit extrait apportant la SOD peut être obtenu par un procédé d'obtention de la SOD ou de l'extrait contenant de la SOD par extraction aqueuse, sans solvant organique. La SOD est en effet une molécule particulièrement fragile qui nécessite des conditions d'extraction douces. La SOD peut également éventuellement être une SOD de synthèse. The composition therefore preferably comprises a melon, vine or olive tree extract containing SOD. When the extract is from a vine, it may be an extract of Vitis vinifero but said extract is not an extract of Vitis vinifera comprising at least 50% of total polyphenols including at least 15% of catechins and/or epicatechins and/ or at least 5% flavanol oligomers. Said extract providing SOD can be obtained by a process for obtaining SOD or the extract containing SOD by aqueous extraction, without organic solvent. SOD is indeed a particularly fragile molecule which requires mild extraction conditions. The SOD may also optionally be a synthetic SOD.
[0062] Préférentiellement, l'extrait de vigne, préférentiellement un extrait de Vitis vinifera est encapsulée ou microencapsulée. Avantageusement, ledit extrait est encapsulée ou microencapsulée dans un support alimentaire choisi parmi une maltodextrine, une gomme arabique, une huile hydrogénée ou non hydrogénée, une cire, des alginates, de l'amidon, des protéines hydrolysées ou non, de la phosphatidylcholine, des phospholipides, du galactomannane, des émulsifiants choisis parmi la pectine ou polyricinoléate de polyglycérol et des fibres choisies parmi la polydextrose, la HPMC et la cellulose. L'encapsulation est particulièrement avantageuse et permet de stabiliser et protéger l'extrait. Preferably, the vine extract, preferably an extract of Vitis vinifera is encapsulated or microencapsulated. Advantageously, said extract is encapsulated or microencapsulated in a food carrier chosen from maltodextrin, gum arabic, hydrogenated or non-hydrogenated oil, wax, alginates, starch, hydrolyzed or non-hydrolyzed proteins, phosphatidylcholine, phospholipids, galactomannan, emulsifiers chosen from pectin or polyglycerol polyricinoleate and fibers chosen from polydextrose, HPMC and cellulose. Encapsulation is particularly advantageous and makes it possible to stabilize and protect the extract.
[0063] Par extrait on entend une molécule ou un mélange de molécules obtenu à partir de ces végétaux. Les extraits contenant de la SOD intégrés dans les compositions selon l'invention peuvent être constitués exclusivement de SOD ou bien de SOD et d'une ou plusieurs autres molécules tel que des polyphénols avec une teneur en SOD d'au moins 100UI/g de matière
sèche de l'extrait et encore plus préférentiellement au moins 500UI /g de matière sèche de l'extrait et encore plus préférentiellement au moins 1000 111/ g de matière sèche de l'extrait. [0064] La SOD (ou l'extrait contenant de la SOD) utilisée selon l'invention est préférentiellement associée à un véhicule approprié pour l'usage visé : usage externe pour une composition cosmétique ou un médicament pour une administration par voie topique ; ingestion et assimilation par l'organisme pour une composition alimentaire ou un complément alimentaire ou un médicament pour une administration par voie orale. En particulier, la SOD est préalablement microencapsulée au sein de microparticules biodégradables polymériques ou de substances lipidiques. By extract is meant a molecule or a mixture of molecules obtained from these plants. The extracts containing SOD incorporated into the compositions according to the invention may consist exclusively of SOD or else of SOD and one or more other molecules such as polyphenols with an SOD content of at least 100 IU/g of material. dry matter of the extract and even more preferably at least 500 IU/g of dry matter of the extract and even more preferably at least 1000 111/g of dry matter of the extract. The SOD (or the extract containing SOD) used according to the invention is preferably associated with a suitable vehicle for the intended use: external use for a cosmetic composition or a medicament for topical administration; ingestion and assimilation by the body for a food composition or a food supplement or a medicament for oral administration. In particular, the SOD is microencapsulated beforehand within polymeric biodegradable microparticles or lipid substances.
[0065] Lorsque la composition comprend de la superoxyde dismutase (SOD), le ratio SOD/Vitamine C dans la composition est préférentiellement compris entre 1 et 50 et la SOD est présente dans la composition en une quantité d'au moins 100 Ul/ g de matière sèche du poids total de la composition, préférentiellement au moins 500 Ul/g de matière sèche du poids total de la composition. When the composition comprises superoxide dismutase (SOD), the SOD/Vitamin C ratio in the composition is preferably between 1 and 50 and the SOD is present in the composition in an amount of at least 100 IU/g. of dry matter of the total weight of the composition, preferably at least 500 IU/g of dry matter of the total weight of the composition.
[0066] La composition selon l'invention, en plus de la SOD, de la vitamine C, de l'extrait de Vitis vinifera et des probiotiques peut contenir d'autres molécules actives efficaces pour la lutte contre le vieillissement cutané, comme le zinc et/ou au moins une autre vitamine choisie parmi les vitamines Bl, B2, B3, B3/PP, B5, B6, B8/H, B9, B12, E et D. [0066] The composition according to the invention, in addition to SOD, vitamin C, Vitis vinifera extract and probiotics, may contain other active molecules that are effective in combating skin aging, such as zinc and/or at least one other vitamin chosen from vitamins B1, B2, B3, B3/PP, B5, B6, B8/H, B9, B12, E and D.
[0067] Lesdites vitamines pouvant être issues de produits naturel, en particulier des fruits et légumes ou de produits de synthèse. Said vitamins may be derived from natural products, in particular fruits and vegetables or synthetic products.
[0068] La composition peut en outre, comprendre au moins un prébiotique choisi parmi l'inuline, les oligosaccharides, FOS (fructo-oligosaccharides), GOS (galacto-oligosaccharides), CLA (conjugated linoleic acid), PUFA (polyunsaturated fatty acid), MOS (mannanoligosaccharide) et XOS (xylooligosaccharide). The composition may also comprise at least one prebiotic chosen from inulin, oligosaccharides, FOS (fructo-oligosaccharides), GOS (galacto-oligosaccharides), CLA (conjugated fatty linoleic acid), PUFA (polyunsaturated acid) , MOS (mannanoligosaccharide) and XOS (xylooligosaccharide).
[0069] L'ajout de prébiotique permet de renforcer l'efficacité de la composition. Lorsqu'elles sont associées, mélangées, combinées avec un extrait de Vitis vinifera, au moins un probiotique et de la vitamine C, la composition présente un effet amélioré sur le vieillissement cutané. [0069] The addition of a prebiotic makes it possible to reinforce the effectiveness of the composition. When they are associated, mixed, combined with an extract of Vitis vinifera, at least one probiotic and vitamin C, the composition exhibits an improved effect on skin aging.
[0070] La composition selon l'invention peut être administrée par voie orale sous forme de complément alimentaire, de produit nutritionnel ou de médicament ou appliquée par voie topique sur la peau sous forme de produit cosmétique ou de médicament adapté à une application topique. Aussi, la composition comprend également des excipients adaptés en
fonction de son mode d'administration. The composition according to the invention can be administered orally in the form of a food supplement, a nutritional product or a medicine or applied topically to the skin in the form of a cosmetic product or a medicine suitable for topical application. Also, the composition also comprises excipients suitable in depending on its mode of administration.
[0071] Pour une administration par voie orale, il peut s'agir en particulier de maltodextrine, d'amidon, de gomme arabique, d'huile végétale, du sorbitol ou d'eau. La composition se présente alors sous forme de poudre, d'huile ou de solution liquide. For oral administration, it may be in particular maltodextrin, starch, gum arabic, vegetable oil, sorbitol or water. The composition is then in the form of a powder, an oil or a liquid solution.
[0072] Pour une administration par voie topique sur la peau, il peut s'agir en particulier d'eau, d'huiles végétales, minérales ou de silicones, de graisses végétales. La composition se présente alors sous forme de crème, pommade, émulsion, gel ou lotion. For topical administration to the skin, it may be in particular water, vegetable, mineral or silicone oils, vegetable fats. The composition is then in the form of a cream, ointment, emulsion, gel or lotion.
[0073] Préférentiellement, la composition est encapsulée ou microencapsulée, préférentiellement la composition est encapsulée ou microencapsulée dans un support alimentaire choisi parmi une maltodextrine, une gomme arabique, une huile hydrogénée ou non hydrogénée, une cire, des alginates, de l'amidon, des protéines hydrolysées ou non, de la phosphatidylcholine, des phospholipides, du galactomannane, des émulsifiants choisis parmi la pectine ou polyricinoléate de polyglycérol et des fibres choisies parmi la polydextrose, la HPMC et la cellulose. Preferably, the composition is encapsulated or microencapsulated, preferably the composition is encapsulated or microencapsulated in a food carrier chosen from maltodextrin, gum arabic, hydrogenated or non-hydrogenated oil, wax, alginates, starch, hydrolyzed or non-hydrolyzed proteins, phosphatidylcholine, phospholipids, galactomannan, emulsifiers chosen from pectin or polyglycerol polyricinoleate and fibers chosen from polydextrose, HPMC and cellulose.
[0074] L'encapsulation est particulièrement avantageuse et permet de stabiliser et protéger l'extrait de Vitis vinifera et/ou la ou les probiotiques (bactéries et/ou levures) de son environnement, notamment de l'organisme. Encapsulation is particularly advantageous and makes it possible to stabilize and protect the Vitis vinifera extract and/or the probiotic(s) (bacteria and/or yeasts) from its environment, in particular from the organism.
[0075] De plus, l'encapsulation permet d'améliorer la stabilité, la biodisponibilité et l'utilisation dudit extrait dans des matrices alimentaires, avec notamment un masquage du goût et une résistance aux possibles altérations des composés pendant les étapes de production d'un produit alimentaire. In addition, encapsulation makes it possible to improve the stability, the bioavailability and the use of said extract in food matrices, with in particular masking of the taste and resistance to possible alterations of the compounds during the stages of production of a food product.
[0076] La microencapsulation procure les mêmes avantages que l'encapsulation mais permet tout particulièrement d'insérer des substances actives au sein de particules de tailles comprises entre 1 pm et 1000 pm et plus préférentiellement entre 30 pm et 500 pm et encore plus préférentiellement entre 50 pm et 300 pm. Microencapsulation provides the same advantages as encapsulation but more particularly makes it possible to insert active substances into particles of size between 1 μm and 1000 μm and more preferentially between 30 μm and 500 μm and even more preferentially between 50pm and 300pm.
[0077] La composition selon l'invention est destinée à être administrée comme produit nutritif et peut donc se présenter sous différentes formes, préférentiellement sous forme de poudre, de gélule, de comprimé, de capsule, d'une solution, d'une suspension, d'une émulsion ou d'une gomme à mâcher. The composition according to the invention is intended to be administered as a nutritive product and can therefore be in different forms, preferably in the form of powder, capsule, tablet, capsule, solution, suspension , emulsion or chewing gum.
[0078] Lorsque la composition est destinée à être administrée comme produit nutritif, elle peut également se présenter sous forme d'un produit alimentaire se présentant préférentiellement sous forme de produits laitiers, purées, céréales, produits céréaliers et
boissons. When the composition is intended to be administered as a nutritional product, it can also be in the form of a food product, preferably in the form of dairy products, purees, cereals, cereal products and drinks.
[0079] Lorsque la composition est administrée comme produit thérapeutique, l'invention se rapporte à une composition pour son utilisation en tant que médicament pour l'Homme ou l'animal et peut se présenter sous différentes formes, préférentiellement sous forme de poudre, de gélule, de comprimé, de comprimé effervescent de capsule, d'une solution, d'une suspension. When the composition is administered as a therapeutic product, the invention relates to a composition for its use as a medicament for humans or animals and can be in different forms, preferably in the form of powder, capsule, tablet, effervescent tablet, capsule, solution, suspension.
[0080] Lorsque la composition est sous forme de médicament, la composition selon l'invention est préférentiellement destinée à être utilisée dans la prévention et/ou le traitement des pathologies cutanées choisies parmi l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée. When the composition is in drug form, the composition according to the invention is preferably intended for use in the prevention and/or treatment of skin pathologies chosen from acne and/or dermatitis and/or erythema and/or eczema and/or rosacea.
[0081] La composition présente également un effet cosmétique anti-âge cutané chez un sujet sain qui se caractérise en particulier par la diminution des imperfections cutanées (tâches, rougeurs, cernes...), le maintien ou la restauration de la fermeté et de l'élasticité de la peau, l'amélioration du teint de la peau (couleurs, luminosité, contraste, brillance...), le maintien ou la restauration d'une bonne hydratation de la peau. [0081] The composition also exhibits a cutaneous anti-aging cosmetic effect in a healthy subject which is characterized in particular by the reduction of cutaneous imperfections (spots, redness, dark circles, etc.), the maintenance or restoration of firmness and the elasticity of the skin, the improvement of the complexion of the skin (colors, luminosity, contrast, shine, etc.), the maintenance or restoration of good hydration of the skin.
[0082] La composition peut être obtenue par le procédé comprenant les étapes suivantes. [0083] Dans un mélangeur, par exemple de type à ruban, en V, à soc (non exhaustif), les composés sous formes sèches, seront mélangés. Optionnellement, un prémélange avec l'extrait contenant la SOD seul ou avec la vitamine C, ajouté à une quantité d'excipient n'excédant pas les 80% en poids du prémélange pourra être fabriqué avant d'être lui-même mélangé avec la totalité des excipients et autres constituants de la formule. Afin d'obtenir un mélange homogène l'opération de mélange pourra durer entre 5 minutes et 30 minutes. [0084] Selon une variante, le procédé peut consister à ajouter directement la vitamine C avec les autres constituants de la formule sous agitation pendant 5 à 30 minutes à une température inférieure à 40°C préférentiellement et éventuellement sous gaz inerte. The composition can be obtained by the process comprising the following steps. [0083] In a mixer, for example of the ribbon, V, plowshare type (not exhaustive), the compounds in dry form will be mixed. Optionally, a premix with the extract containing SOD alone or with vitamin C, added to a quantity of excipient not exceeding 80% by weight of the premix may be manufactured before being itself mixed with the total excipients and other constituents of the formula. In order to obtain a homogeneous mixture, the mixing operation may last between 5 minutes and 30 minutes. According to a variant, the method may consist in directly adding vitamin C with the other constituents of the formula with stirring for 5 to 30 minutes at a temperature below 40° C., preferably and optionally under inert gas.
[0085] Pour les compositions sous des formes liquides, pâteuses, gélifiées, il convient, sous agitation, de disperser finement la vitamine C dans la phase hydrophile. Lorsque la composition comprend de la SOD, l'extrait contenant la SOD pourra, lui, être dispersé finement dans la phase lipophile contenant un émulsifiant. La température de la phase lipophile n'excèdera pas préférentiellement 40°C. Les 2 phases pourront alors être mélangées entre 5 minutes et 30 minutes jusqu'à obtention d'un mélange homogène. For compositions in liquid, pasty or gelled forms, it is appropriate, with stirring, to finely disperse the vitamin C in the hydrophilic phase. When the composition comprises SOD, the extract containing the SOD may itself be finely dispersed in the lipophilic phase containing an emulsifier. The temperature of the lipophilic phase will preferably not exceed 40°C. The 2 phases can then be mixed between 5 minutes and 30 minutes until a homogeneous mixture is obtained.
[0086] Pour les formes sèches, le produit, une fois mélangé, sera conditionné dans la
galénique adaptée au produit fini (gélule, comprimé, stick) selon les techniques classiques et connues de l'homme du métier. [0086] For the dry forms, the product, once mixed, will be packaged in the galenic adapted to the finished product (capsule, tablet, stick) according to conventional techniques known to those skilled in the art.
[0087] Pour les formes liquides, le mélange pourra être homogénéisé à l'aide d'un homogénéisateur et pourra éventuellement également faire l'objet d'une étape de pasteurisation ou de stérilisation avant conditionnement selon les techniques connues et classiques de l'homme du métier. For liquid forms, the mixture may be homogenized using a homogenizer and may also possibly undergo a pasteurization or sterilization step before packaging according to known and conventional techniques. of career.
[0088] Utilisation et procédé de traitement cosmétique [0088] Use and method of cosmetic treatment
[0089] L'invention a également pour objet un procédé de traitement cosmétique de la peau, pour prévenir et/ou lutter contre les manifestations visibles du vieillissement normal de la peau, qui consiste à appliquer sur la peau, en particulier sur la peau du visage, au moins une fois par jour une composition cosmétique selon l'invention, adaptée à une administration par voie topique sur la peau. Une application biquotidienne est préférée. The invention also relates to a method for the cosmetic treatment of the skin, to prevent and/or combat the visible manifestations of normal aging of the skin, which consists in applying to the skin, in particular to the skin of the face, at least once a day, a cosmetic composition according to the invention, suitable for topical administration to the skin. Twice daily application is preferred.
[0090] L'invention vise aussi un procédé de traitement cosmétique pour prévenir et/ou lutter contre les manifestations visibles du vieillissement normal de la peau, qui consiste à ingérer, au moins une fois par jour, une composition nutritionnelle ou une composition cosmétique selon l'invention adaptée à une administration par voie orale, en particulier un complément alimentaire à effet cosmétique. The invention also relates to a cosmetic treatment process for preventing and/or combating the visible manifestations of normal skin aging, which consists in ingesting, at least once a day, a nutritional composition or a cosmetic composition according to the invention suitable for oral administration, in particular a food supplement with a cosmetic effect.
[0091] Selon un autre objet, l'invention vise une utilisation cosmétique de la composition selon l'invention, pour un effet cosmétique anti-âge et/ou hydratant et/ou pour lutter contre le feu du rasoir. According to another object, the invention is aimed at a cosmetic use of the composition according to the invention, for an anti-aging and/or moisturizing cosmetic effect and/or for combating razor burn.
[0092] Préférentiellement, l'utilisation cosmétique de la présente composition vise à obtenir un effet cosmétique permettant : Preferably, the cosmetic use of the present composition aims to obtain a cosmetic effect allowing:
- de diminuer les imperfections cutanées telles que les tâches, les rougeurs et/ou les cernes, et/ou - to reduce skin imperfections such as spots, redness and/or dark circles, and/or
- de maintenir et/ou restaurer la fermeté et l'élasticité de la peau et/ou - to maintain and/or restore the firmness and elasticity of the skin and/or
- d'améliorer le teint de la peau et/ou de maintenir et/ou améliorer l'hydratation de la peau. - to improve the complexion of the skin and/or to maintain and/or improve the hydration of the skin.
[0093] Exemples [0093] Examples
[0094] Exemple 1 : Composition nutritionnelle destinée à l'homme [0095] L'exemple 1 est une gélule de 381 mg, constituée par : [0094] Example 1: Nutritional composition intended for humans [0095] Example 1 is a 381 mg capsule, consisting of:
Un extrait de Vitis vinifero : 250 mg Vitamine C : 6 mg
Mélange de 6 probiotiques (Lactobacillus fermentum, L plantarum, L acidophilus, Bfidobacterium lactis, B. longum, B. bifidum) 3c10L9 CFU : 75 mg Maltodextrine : 50 mg. An extract of Vitis vinifero: 250 mg Vitamin C: 6 mg Blend of 6 probiotics (Lactobacillus fermentum, L plantarum, L acidophilus, Bfidobacterium lactis, B. longum, B. bifidum) 3c10 L 9 CFU: 75 mg Maltodextrin: 50 mg.
La composition est obtenue par mélange des constituants dans les conditions classiques connues de l'homme du métier, et mis dans une gélule selon les conditions classiques également. La posologie préconisée est de 2 gélules par jour. The composition is obtained by mixing the constituents under the conventional conditions known to those skilled in the art, and placed in a capsule according to the conventional conditions as well. The recommended dosage is 2 capsules per day.
[0096] Exemple 2 : Composition nutritionnelle destinée à l'homme [0097] L'exemple 2 est un sachet de 3200 mg, constitué par : [0096] Example 2: Nutritional composition intended for humans [0097] Example 2 is a 3200 mg sachet, consisting of:
Un extrait de Vitis vinifero : 600 mg Vitamine C : 12 mg SOD : 100 mg An extract of Vitis vinifero: 600 mg Vitamin C: 12 mg SOD: 100 mg
Mélange de 3 probiotiques (Lactobacillus acidophilus , Bifidobacterium bifidum,Blend of 3 probiotics (Lactobacillus acidophilus, Bifidobacterium bifidum,
Lactobacillus fermentum) 4c10L9 CFU : 2300 mg Lactobacillus fermentum) 4c10 L 9 CFU: 2300 mg
Zinc : 3 mg Zinc: 3mg
Vitamine B6 : 0,5 mg Vitamin B6: 0.5mg
Maltodextrine : 184,5 mg. Maltodextrin: 184.5 mg.
La composition est obtenue par mélange des constituants dans les conditions classiques connues de l'homme du métier et se présente sous forme d'une poudre contenue dans un sachet selon les conditions classiques également. La posologie préconisée est de 1 sachet par jour. The composition is obtained by mixing the constituents under conventional conditions known to those skilled in the art and is in the form of a powder contained in a sachet also under conventional conditions. The recommended dosage is 1 sachet per day.
[0098] Exemple 3 : Composition nutritionnelle destinée à l'animal [0099] L'exemple 3 est une capsule molle constituée par : [0098] Example 3: Nutritional composition intended for animals [0099] Example 3 is a soft capsule consisting of:
Un extrait de Vitis vinifera : 50 mg Vitamine C : 24 mg SOD : 50 mg An extract of Vitis vinifera: 50 mg Vitamin C: 24 mg SOD: 50 mg
Mélange de 2 probiotiques (Enterocossus faecium, Lactobacillus acidophilus casei) 3c10L9 CFU : 21 mg - FOS : 100 mg Mixture of 2 probiotics (Enterocossus faecium, Lactobacillus acidophilus casei) 3c10 L 9 CFU: 21 mg - FOS: 100 mg
Huile d'onagre : 400 mg. Evening primrose oil: 400 mg.
La composition est obtenue par mélange des constituants dans les conditions classiques connues de l'homme du métier et se présente sous forme d'une capsule molle selon les conditions classiques également. La posologie préconisée est de 1 capsule par jour.
[0100] Exemple 4 : Composition nutritionnelle destinée à l'animal The composition is obtained by mixing the constituents under the standard conditions known to those skilled in the art and is in the form of a soft capsule also under the standard conditions. The recommended dosage is 1 capsule per day. Example 4: Nutritional composition intended for the animal
[0101] L'exemple 4 est un comprimé constitué par : Example 4 is a tablet consisting of:
Un extrait de Vitis vinifero : 50 mg Vitamine C : 5 mg - SOD : 50 mg An extract of Vitis vinifero: 50 mg Vitamin C: 5 mg - SOD: 50 mg
Mélange de 5 probiotiques (Lactobacillus acidophilus, L. plantarum, L Brevis, Bifidobacterium animalis lactis, Lactobacillus ramnosus) 2c10L9 CFU : 26.5 mg - FOS : 250 mg. Blend of 5 probiotics (Lactobacillus acidophilus, L. plantarum, L Brevis, Bifidobacterium animalis lactis, Lactobacillus ramnosus) 2c10 L 9 CFU: 26.5 mg - FOS: 250 mg.
La composition est obtenue par mélange des constituants dans les conditions classiques connues de l'homme du métier et se présente sous forme d'un comprimé selon les conditions classiques également. La posologie préconisée est de 1 comprimé par jour pour un chien de 10 Kg.
The composition is obtained by mixing the constituents under the standard conditions known to those skilled in the art and is in the form of a tablet also under the standard conditions. The recommended dosage is 1 tablet per day for a 10 kg dog.
Claims
[Revendication 1] Composition comprenant : au moins de la vitamine C, au moins un extrait de Vitis vinifera, et au moins une bactérie probiotique et/ou levure probiotique. [Claim 1] Composition comprising: at least vitamin C, at least one extract of Vitis vinifera, and at least one probiotic bacterium and/or probiotic yeast.
[Revendication 2] Composition selon la revendication précédente, caractérisé en ce que l'extrait de Vitis vinifero comprend un mélange de molécules comprenant au moins 50% de polyphénols totaux mesurés par spectrophotométrie à une DO280nm, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, lesdits polyphénols totaux comprenant : au moins 15% de monomères de flavanols mesurés par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera, au moins 5% d'oligomères de flavanols mesuré par HPLC, le pourcentage étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera. [Claim 2] Composition according to the preceding claim, characterized in that the extract of Vitis vinifero comprises a mixture of molecules comprising at least 50% of total polyphenols measured by spectrophotometry at OD280nm, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, said total polyphenols comprising: at least 15% of flavanol monomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera, at least 5% of flavanol oligomers measured by HPLC, the percentage being given by dry weight relative to the total dry weight of the extract of Vitis vinifera.
[Revendication 3] Composition selon la revendication précédente, caractérisé en ce que le mélange de molécules comprend également au moins 15 ppm de stilbènes, le poids étant donné en poids sec par rapport au poids total sec de l'extrait de Vitis vinifera. [Claim 3] Composition according to the preceding claim, characterized in that the mixture of molecules also comprises at least 15 ppm of stilbenes, the weight being given in dry weight relative to the total dry weight of the extract of Vitis vinifera.
[Revendication 4] Composition selon la revendication précédente, comprenant au moins de la superoxyde dismutase (SOD), caractérisé en ce que le ratio SOD/ Vitamine C dans la composition est compris entre 1 et 50 et en ce que la SOD est présente dans la composition en une quantité d'au moins 100 111/ g de matière sèche du poids total de la composition. [Claim 4] Composition according to the preceding claim, comprising at least superoxide dismutase (SOD), characterized in that the SOD/Vitamin C ratio in the composition is between 1 and 50 and in that the SOD is present in the composition in an amount of at least 100 µl/g of dry matter of the total weight of the composition.
[Revendication 5] Composition selon la revendication précédente, caractérisée en ce que la SOD est issue de vigne, ou de melon ou de l'olivier. [Claim 5] Composition according to the preceding claim, characterized in that the SOD is derived from vines, or melon or olive trees.
[Revendication 6] Composition selon l'une des revendications précédentes, caractérisée en ce que la vitamine C est présente dans la composition en une quantité d'au moins lmg/ g de matière sèche du poids total de la composition.
[Claim 6] Composition according to one of the preceding claims, characterized in that the vitamin C is present in the composition in an amount of at least 1 mg/g of dry matter of the total weight of the composition.
[Revendication 7] Composition selon l'une des revendications précédentes, caractérisée en ce que la bactérie probiotique et/ou levure probiotique est morte, inactivée, semi-inactivée ou vivante, sous forme de spores ou non.[Claim 7] Composition according to one of the preceding claims, characterized in that the probiotic bacterium and/or probiotic yeast is dead, inactivated, semi-inactivated or alive, in the form of spores or not.
[Revendication 8] Composition selon l'une des revendications précédentes, caractérisée en ce la (les) bactérie(s) ou levure(s) probiotique(s) est choisie parmi les genres Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Enterococcus, Pediococcus, Escherichia et leurs mélanges.[Claim 8] Composition according to one of the preceding claims, characterized in that the probiotic bacterium(ies) or yeast(s) is chosen from the genera Lactobacillus, Bifidobacterium, Streptococcus, Saccharomyces, Enterococcus, Pediococcus, Escherichia and their mixtures.
[Revendication 9] Composition selon la revendication précédente, caractérisée en ce que la (les) bactérie(s) ou levure(s) probiotique(s) est choisie parmi les espèces Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus delbrueckii ssp bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus rhamnosus ; Bifidobacterium bifidum, Bifidobacterium animalis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium animalis , Bifidobacterium bifidum,[Claim 9] Composition according to the preceding claim, characterized in that the probiotic bacterium(ies) or yeast(s) is chosen from the species Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus delbrueckii ssp bulgaricus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus rhamnosus; Bifidobacterium bifidum, Bifidobacterium animalis, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium animalis, Bifidobacterium bifidum,
Bifidobacterium breve, Streptococcus thermophiles, Sacaromyces cerevisiae, Streptococcus faecium, Enterococcus Faecalis, Escherichia coli et leurs mélanges. Bifidobacterium breve, Streptococcus thermophiles, Sacaromyces cerevisiae, Streptococcus faecium, Enterococcus Faecalis, Escherichia coli and their mixtures.
[Revendication 10] Composition selon l'une des revendications précédentes caractérisée en ce que la composition apporte journalièrement entre lxlO5 et 9xl012 UFC, préférentiellement entre lxlO7 et 9x1o11 d'une bactérie probiotique et/ou levure et/ou d'un mélange. [Claim 10] Composition according to one of the preceding claims, characterized in that the composition provides between 1x10 5 and 9x10 12 CFU daily, preferably between 1x10 7 and 9x10 11 of a probiotic bacterium and/or yeast and/or a mixed.
[Revendication 11] Composition selon l'une des revendications précédentes, caractérisée en ce qu'elle comprend également au moins du zinc et/ou au moins une autre vitamine choisie parmi les vitamines Bl, B2, B3, B3/PP, B5, B6, B8/H, B9, B12, E et D. [Claim 11] Composition according to one of the preceding claims, characterized in that it also comprises at least zinc and/or at least one other vitamin chosen from vitamins B1, B2, B3, B3/PP, B5, B6 , B8/H, B9, B12, E and D.
[Revendication 12] Composition selon l'une des revendications précédentes, caractérisée en ce qu'elle comprend également au moins un prébiotique.
[Claim 12] Composition according to one of the preceding claims, characterized in that it also comprises at least one prebiotic.
[Revendication IB] Composition selon la revendication précédente, caractérisée en ce que les prébiotiques sont choisis parmi FOS, GOS et des polyphénols issus de fruits rouges. [Claim IB] Composition according to the preceding claim, characterized in that the prebiotics are chosen from FOS, GOS and polyphenols derived from red fruits.
[Revendication 14] Composition selon l'une des revendications précédentes pour son utilisation dans la prévention et/ou le traitement de l'acné et/ou la dermatite et/ou l'érythème et/ou l'eczéma et/ou la rosacée. [Claim 14] Composition according to one of the preceding claims for its use in the prevention and/or treatment of acne and/or dermatitis and/or erythema and/or eczema and/or rosacea.
[Revendication 15] Composition selon l'une des revendications 1 à 14, caractérisée en ce que la composition est un complément alimentaire se présentant sous forme de gélule, poudre, comprimé, solution ou gomme à mâcher. [Claim 15] Composition according to one of Claims 1 to 14, characterized in that the composition is a food supplement in the form of a capsule, powder, tablet, solution or chewing gum.
[Revendication 16] Composition selon l'une des revendications 1 à 14, caractérisée en ce que la composition est un produit alimentaire se présentant sous forme de produits laitiers, céréales, produits céréaliers ou boissons.[Claim 16] Composition according to one of Claims 1 to 14, characterized in that the composition is a food product in the form of dairy products, cereals, cereal products or beverages.
[Revendication 17] Composition selon l'une des revendications 1 à 14, caractérisée en ce que la composition est une composition cosmétique se présentant sous forme d'une crème, lotion, gel, mousse, pommade, cataplasme ou patch.
[Claim 17] Composition according to one of Claims 1 to 14, characterized in that the composition is a cosmetic composition in the form of a cream, lotion, gel, mousse, ointment, poultice or patch.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FRFR2101897 | 2021-02-26 | ||
FR2101897A FR3120188B3 (en) | 2021-02-26 | 2021-02-26 | Composition comprising an extract of Vitis vinifera, vitamin C and probiotics to fight against skin aging |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022180231A1 true WO2022180231A1 (en) | 2022-09-01 |
Family
ID=80785074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/054838 WO2022180231A1 (en) | 2021-02-26 | 2022-02-25 | Composition comprising an extract of vitis vinifera, vitamin c and probiotics for combating ageing of the skin |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3120188B3 (en) |
WO (1) | WO2022180231A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100278908A1 (en) * | 2008-10-29 | 2010-11-04 | Edoardo Messora | Compositions incorporating agents for reducing cellulite and unaesthetic appearance associated therewith and formulations containing them |
AU2011242403A1 (en) * | 2010-04-20 | 2012-12-06 | Fit-Bioceuticals Pty Ltd | Combined method for improving the health of skin |
US8361517B2 (en) * | 2007-10-16 | 2013-01-29 | Actigenomics S.A. | Composition for regulating lipid metabolism |
FR3003164A1 (en) | 2013-03-13 | 2014-09-19 | Activ Inside | COMPOSITION CONTAINING SUPEROXIDE DISMUTASE FROM VITIS VINIFERA |
FR3049858A1 (en) | 2016-04-12 | 2017-10-13 | Activ'inside | USE OF A COMPOSITION COMPRISING SOD AND VITAMIN C FOR ANTI-AGE COSMETIC EFFECT |
WO2021115610A1 (en) * | 2019-12-12 | 2021-06-17 | Quantum Pharmaceuticals Sa | Method for preparing a composition and use of the composition for treatment or prophylaxis of disease |
-
2021
- 2021-02-26 FR FR2101897A patent/FR3120188B3/en active Active
-
2022
- 2022-02-25 WO PCT/EP2022/054838 patent/WO2022180231A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8361517B2 (en) * | 2007-10-16 | 2013-01-29 | Actigenomics S.A. | Composition for regulating lipid metabolism |
US20100278908A1 (en) * | 2008-10-29 | 2010-11-04 | Edoardo Messora | Compositions incorporating agents for reducing cellulite and unaesthetic appearance associated therewith and formulations containing them |
AU2011242403A1 (en) * | 2010-04-20 | 2012-12-06 | Fit-Bioceuticals Pty Ltd | Combined method for improving the health of skin |
FR3003164A1 (en) | 2013-03-13 | 2014-09-19 | Activ Inside | COMPOSITION CONTAINING SUPEROXIDE DISMUTASE FROM VITIS VINIFERA |
FR3049858A1 (en) | 2016-04-12 | 2017-10-13 | Activ'inside | USE OF A COMPOSITION COMPRISING SOD AND VITAMIN C FOR ANTI-AGE COSMETIC EFFECT |
WO2021115610A1 (en) * | 2019-12-12 | 2021-06-17 | Quantum Pharmaceuticals Sa | Method for preparing a composition and use of the composition for treatment or prophylaxis of disease |
Non-Patent Citations (5)
Title |
---|
ANONYMOUS: "3 In 1 Complete Detox & Cleanse", GNPD, 30 June 2006 (2006-06-30), XP002696792 * |
ANONYMOUS: "bioclinic naturals - Product Guide", 1 June 2020 (2020-06-01), pages 1 - 60, XP055899011, Retrieved from the Internet <URL:https://bioclinicnaturals.com/en-ca/wp-content/uploads/2021/01/9223226_BCN_ProdGuide_CDN_E_June2020_LRz.pdf> * |
DATABASE GNPD [online] MINTEL; 11 April 2016 (2016-04-11), ANONYMOUS: "BrightLight Intensive Pigmentation & Dark Spot Serum", XP055650265, retrieved from https://www.gnpd.com/sinatra/recordpage/3897169/ Database accession no. 3897169 * |
DATABASE GNPD [online] MINTEL; 16 November 2011 (2011-11-16), ANONYMOUS: "Immuno-Build Greens", XP055933553, retrieved from https://www.gnpd.com/sinatra/recordpage/1662389/ Database accession no. 1662389 * |
DATABASE GNPD [online] MINTEL; 26 March 2020 (2020-03-26), ANONYMOUS: "Natural Mixed Fruit Nourishing Superfood", XP055933527, retrieved from https://www.gnpd.com/sinatra/recordpage/7455163/ Database accession no. 7455163 * |
Also Published As
Publication number | Publication date |
---|---|
FR3120188B3 (en) | 2023-09-22 |
FR3120188A3 (en) | 2022-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2654766B1 (en) | Extract of the pulp and/or peel of avocado rich in polyphenols and cosmetic, dermatologic or nutraceutic compositions comprising thereof | |
EP2459161B1 (en) | Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra sphenanthera | |
RU2572698C2 (en) | Probiotic bacteria having antioxidant activity and use thereof | |
EP2654765B1 (en) | Extract of the aerial parts of maca rich in polyphenol and composition comprising the extract | |
EP3060228B1 (en) | Lipid extract of passion fruit seeds | |
EP3368055A1 (en) | Specific nutritional or therapeutic agent including a mixture of grape and blueberry | |
WO2007026101A1 (en) | Method of obtaining a plant extract from pome fruit, plant extract thus obtained and use of same | |
FR3080989A1 (en) | LIQUID COMPOSITION COMPRISING AN EXTRACT OF CASSIS LEAVES AND CONCENTRATED APPLE JUICE | |
FR3095761A1 (en) | Nutraceutical composition to induce weight loss and reduce abdominal fat | |
WO2009141543A1 (en) | Use of a berry extract, especially a wolfberry extract, as an anti-pollutant | |
WO2022018281A2 (en) | Composition comprising a mixture of extracts of vitis vinifera and vaccinium angustifolium and probiotics to improve cognitive function | |
FR3005418A1 (en) | PETROSELINIC ACID OR ASSOCIATED ASSETS COMPRISING AT LEAST PETROSELINIC ACID TO PROMOTE WEIGHT LOSS AND / OR WEIGHT RETENTION | |
EP3247466B1 (en) | Peptide and glycoside extract of schizandra fruit and improvement in the response of the cutaneous neurosensory system | |
KR20180114629A (en) | Composition for anti inflammation comprising extract of ginseng floral axis | |
WO2022180231A1 (en) | Composition comprising an extract of vitis vinifera, vitamin c and probiotics for combating ageing of the skin | |
WO2020225319A1 (en) | Agrimony extract as anti-pollution agent | |
WO2020260500A1 (en) | Combination product for helping maintain the natural defenses of the organism | |
WO2020260506A1 (en) | Combination product for helping maintain the natural defenses of the organism | |
JP2019182863A (en) | Skin firmness or moisture improving composition | |
WO2023144289A1 (en) | Use of a mixture of flavanols to increase the concentration of the active form of vitamin d, calcitriol | |
WO2021209455A1 (en) | Composition for improving cognitive function | |
KR101613681B1 (en) | Composition for antioxidant comprising extract of Lagerstroemia ovalifolia | |
FR3129831A1 (en) | Use of a composition based on Crocus sativus as a prebiotic | |
FR3124947A1 (en) | Ingestible composition (Ci) for use in the treatment of a skin disorder induced by an intestinal disorder | |
CA3146410A1 (en) | Composition for the treatment of emotional disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22710984 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22710984 Country of ref document: EP Kind code of ref document: A1 |